Upload
nguyenkiet
View
217
Download
3
Embed Size (px)
Citation preview
Marex Spectron Group Limited
Annual Report and Financial Statements
Year ended 31 December 2016
Registration Number 05613060
Marex Spectron Group Limited
1
TABLE OF CONTENTS
Company Information ................................................................................................................................................... 2
Directors’ Report .......................................................................................................................................................... 3
Directors’ Responsibilities Statement........................................................................................................................... 8
Strategic Report ............................................................................................................................................................ 9
Independent Auditor’s Report .................................................................................................................................... 25
Consolidated Income Statement ................................................................................................................................. 27
Consolidated Statement of Other Comprehensive Income ......................................................................................... 27
Statements of Financial Position ................................................................................................................................ 28
Statement of the Changes in Equity and Movements in Reserves ............................................................................. 30
Cash Flow Statements ................................................................................................................................................ 31
Notes to the Financial Statements............................................................................................................................... 33
Marex Spectron Group Limited
2
COMPANY INFORMATION
Country of Incorporation England and Wales
Legal Form Private limited company
Directors S J N Heale (Chairman)
I T Lowitt (Chief Executive Officer)
J H Baldwin
J C Cohen
Lord S Fink
D A Hallgarten
J M Isaacs CBE
P Kadas
J E Nader
R B Nagioff
V Pignatti-Morano Campori
S H Sparke
C R Stent
S Van Den Born
Company Secretary D A Harvey
Registered Office 155 Bishopsgate, London, EC2M 3TQ
Auditors Deloitte LLP
Hill House, 1 Little New Street, London, EC4A 3TR
Bankers Lloyds Bank plc
25 Gresham Street, London, EC2V 7HN
Bank Leumi (UK) plc
20 Stratford Place, London, W1C 1BG
HSBC Bank plc
Level 19, 8 Canada Square, London, E14 5HQ
Barclays Bank plc
1 Churchill Place, London, E13 5BH
Marex Spectron Group Limited
3
DIRECTORS’ REPORT
The directors present their report and audited consolidated financial statements of Marex Spectron Group Limited
(‘Marex Spectron’, ‘the Group’ or ‘the firm’) and the standalone financial statements for Marex Spectron Group
Limited (‘the Company’) for the year ended 31 December 2016.
About Marex Spectron
Marex Spectron is a leading independent global commodities brokerage headquartered in London with a global
network spanning Asia and North America, with dominant market shares in many major agricultural, metal and
energy products. The firm has a broad range of clients including commodity producers and consumers, banks,
hedge funds, asset managers, brokers, commodity trading advisors and professional traders.
We are members of the London Metal Exchange (‘the LME’), where we are a Category 1 Member and Ring
Dealer; the CME Group of exchanges (‘the CME’), the Intercontinental Exchange group of exchanges (‘ICE’) and
many others.
We are regulated in the UK by the Financial Conduct Authority (‘the FCA’, which also regulates our Group under
consolidated supervision), in the US by the National Futures Association (‘the NFA’) and the US Commodities
Futures Trading Commission (‘the CFTC’), in Hong Kong by the Securities and Futures Commission (‘the SFC’),
and in Singapore by the Monetary Authority of Singapore (‘the MAS’) and the International Exchange Singapore
(‘the IES’).
We believe Marex Spectron is the world’s leading commodity broker because of our unique competitive attributes:
1. our unrivalled breadth of commodity market coverage across Energy, Metals and Agricultural products;
2. extensive depth of services across Commodity Brokerage in each market segment and Financial Futures
and Options;
3. a diversified client base consisting of blue chip commodity producers / consumers as well as leading
financial players in our market;
4. an efficient and scalable platform; and
5. leading proprietary technology, data and analytic offerings.
While other competitors might match our offering in one specific commodity category, we are unique in being top
ranked across Metals (number 1 on LME), Energy (top 3 in all major products globally) and Agricultural (number
1 in global softs options).
In Energy, we provide agency brokerage across over-the-counter (‘OTC’) and Exchange-Cleared Contracts with a
focus on Fuel Oil, Natural Gas, Iron Ore, Coal, Crude, Light Ends, Environmental and Freight.
In Metals, we provide brokerage and market making services for base and precious metals (Aluminium, Copper,
Nickel, Zinc, Lead and Gold). We are the leading Ring Dealer on the LME.
In Agriculture, we are primarily a broker, but also provide market making in specific option products (Cocoa,
Coffee, Sugar and European Grains).
Around 60% of our commissions are generated by commodity producers / consumers and 40% by financial
companies who participate in our markets. We do substantial business with essentially all the largest participants in
commodities.
We are deeply embedded in the global commodity market infrastructure, with 35 exchanges in our connectivity
networks. We clear over 150 million contracts a year on exchange and execute over 26 million trades a year for
our clients. We operate out of 11 offices globally with 500 employees in Europe, North America and Asia.
Increasingly, we are providing our clients not just with access to market liquidity, and to management of order flow
(screen, voice and Direct Market Access), but also data and analysis. Funds and money managers are ever more
reliant on quantitative data to support trading and execution decisions. To fill the gap in the market resulting from
banks scaling back and attract institutional clients, Marex Spectron has invested in ‘Intelligence’ (including
proprietary models) and 'Content' (quotes, reports, research) which provide advantage over traditional client
technology providers, and enables us to differentiate ourselves from brokerage competitors. Our NEON platform
in Metals and Nanolytics data is a leader in the industry.
Marex Spectron Group Limited
DIRECTORS’ REPORT (CONTINUED)
4
Chief Executive Officer’s Review
2016 was a record year for the firm, as we maintained our positive earnings trajectory delivering profits before tax
(‘PBT’) of $27 million, up from $17.6 million in 2015. We have now shown improvement in profitability over a
four-year period.
While over the past few years our earning improvement has been driven largely by exiting unprofitable activities
and resource optimisation, in 2016 we effected an important shift in focus, with an emphasis on finding additional
ways to grow our business – and increasing our earnings – through the addition of new talent, new products and the
expansion of our geographic footprint.
This focus on growth is evident in all our geographies, and across all our products:
▪ in North America, we opened a new office in Calgary and hired a leading Canadian physical oil team,
as well as built the systems necessary for them to begin broking in January 2017. We hired a leading
Light Ends broker in the US and we also entered the US Power business;
▪ in Asia, we launched a Metals trading capability in Singapore – a move that reflects the importance of
the Asian markets and the time zone to our global business – and we built-out a leading Light Ends
brokerage business;
▪ in Europe, we built a team to broker Clean Freight in London and developed our Energy Clearing
capabilities. In Financial Futures and Options, we hired a high quality team in anticipation of an
improving environment for this business;
▪ in our Metals business, we are building out an OTC offering, developing an alternative marketplace to
LME’s electronic platform, and leveraging our new NEON trading platform to win electronic business;
▪ in Agriculture, we restructured the grains trading desk to improve risk adjusted returns, rolled out a
new investment product to select clients, and expanded trading in the US; and
▪ we operationally launched our Nanolytics quant commodities fund. Nanolytics utilises Marex
Spectron’s institutional scale infrastructure to process enormous quantities of publically available data,
covering 24 commodity markets to deliver insight into underlying demand-supply balances which
indicate likely future price movement.
To deliver many of these initiatives, we have been able to leverage off the capabilities we have built in our Support
and Control team.
This was ably demonstrated at the Canada launch, where in two months we developed, essentially from scratch, an
interactive electronic marketplace that allows users to view and trade over 500 separate products.
To support the new Energy Clearing business, we joined a new exchange and clearing house (that supports five
exchanges) and developed a straight through processing (‘STP’) solution, all of which was achieved in just three
months.
Building a strong Marex Spectron culture, based on our values of respect for clients, personal integrity,
collaboration, developing our people and adaptability, is an important management priority. This underpins our
commitment to a world class control environment, excellent risk management and great client service. We know
that our people are the basis of our competitive advantage and we have developed an environment where ambitious,
hardworking and talented people choose to build their careers and are excited to work.
To help us further develop our business, we increased on liquidity resources, adding Barclays as the third bank to
our Working Capital Facility, and strengthened our relationships with a core set of banks.
We are proud of what we have accomplished over the past year in challenging market conditions and look forward
to 2017. We will continue to be prudent and sensible, maintaining our strong liquidity and capital profile,
alongside a lean cost structure, and we anticipate revenue growth from our various initiatives. We are winning
clients, adding to our offerings and gaining market share, all of which is reflecting our increasing competitiveness.
As we look to build a great firm, I would like to thank the employees at Marex Spectron for their effort and hard
work.
Marex Spectron Group Limited
DIRECTORS’ REPORT (CONTINUED)
5
Conclusion and future developments
In 2016, Marex Spectron continued its strong earnings growth achieving record levels of profit. Importantly, in
2016, the firm invested broadly across products and geographies to increase diversification and provide a strong
platform for future growth.
While the Group is well positioned to benefit from improving commodity markets, it is not reliant on such
improvement; the organisation has worked hard to increase its competitiveness, in particular improving content,
market intelligence and technology capabilities. The firm has increased market share, attracted new clients and
hired some of the best talent in the world. The future is always uncertain but management is confident that Marex
Spectron is well placed to continue its positive growth.
The directors, in preparing this strategic report, have complied with s414C of the Companies Act 2006.
I T Lowitt
Chief Executive Officer
29 March 2017
Directors
The following directors have held office throughout the year and to the date of this report, except where noted:
Appointed Resigned
S J N Heale (Chairman)
I T Lowitt (Chief Executive Officer)
J H Baldwin 1 March 2016
J C Cohen
Lord S Fink
D A Hallgarten
J M Isaacs CBE
P Kadas
J E Nader 15 February 2016
R B Nagioff
V Pignatti-Morano Campori
S H Sparke
C R Stent
P M Sugarman 15 February 2016
S Van Den Born 1 March 2016
J P Wall 8 January 2016
Indemnity of directors
Each director is indemnified out of the assets of the Group against all costs, charges, losses and liabilities incurred
by them in the proper exercise of their duties. Directors who have resigned during the year also benefit from the
same indemnity arrangement. In addition, the directors are covered by an insurance policy.
Marex Spectron Group Limited
DIRECTORS’ REPORT (CONTINUED)
6
Directors’ statement as to disclosure of information to the Auditor
Each of the persons, who is a director at the date of approval of this report, confirms that:
▪ so far as he / she is aware, there is no relevant audit information of which the Group’s auditor is
unaware; and
▪ that he / she has taken all the steps that he / she ought to have taken as a director in order to make
himself / herself aware of any relevant audit information and to establish that the Group’s auditor is
aware of that information.
This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies
Act 2006.
Charitable and political contributions
Marex Spectron maintains a $100,000 per annum fund to support employees in their charitable fundraising
activities. It does this by donating 50% of the sum raised by the employee to the chosen charities. In order to
ensure that the fund can be accessed by as many employees as possible, donations from the company are capped at
$2,500 per fundraising event. The total charitable donations from this programme were $35,792 during the year
ended 31 December 2016 (2015: $28,995).
No contributions were made for political purposes during the year (2015: $nil).
Foreign exchange
The following foreign exchange rates have been used in the preparation of these financial statements:
2016 2015
Average
Rate
Year-end
Rate
Average
Rate
Year-end
Rate
GBP / USD 1.3554 1.2345 1.5248 1.4738
USD / EUR 1.1070 1.0524 1.1031 1.0855
Going concern
After reviewing the Group and Company’s annual budget, liquidity requirements, plans and financial arrangements
the directors are satisfied that the Group and Company have adequate resources to continue to operate for the
foreseeable future and for at least 12 months from the date of signing of the balance sheet and confirm that the
Group and Company are a going concern. For this reason they continue to adopt the going concern basis in the
preparation of these financial statements.
Events after the reporting period
Events since the statement of financial position date are disclosed in note 34.
Overseas branches
The Group has branches in the US, Canada, Germany, and Norway.
Dividends
During the year, Marex Spectron Group Limited declared and paid a dividend of $20 million (2015: $ nil).
Financial risk management
Financial risk management objectives are included in the strategic report.
Future developments
Future developments are included in the strategic report.
Marex Spectron Group Limited
DIRECTORS’ REPORT (CONTINUED)
7
Suppliers
Terms and conditions for business transactions are agreed individually with suppliers. Payment is then made on
these terms subject to the terms and conditions being met by the suppliers including the timely submission of
satisfactory invoices.
Employees
Applications for employment by disabled persons are always fully considered, bearing in mind the respective
aptitudes and abilities of the applicant concerned. In the event of members of staff becoming disabled, every effort
is made to ensure that their employment with the Group continues and that appropriate training is arranged. It is
the policy of the Group that the training, career development and promotion of a disabled person should, as far as
possible, be identical to that of a person who does not suffer from a disability. The Group places considerable
value on the involvement of its employees and has continued to keep them informed on matters affecting them as
employees and on the various factors affecting the performance of the Group and the Company. This is achieved
through formal and informal meetings and the Group website.
Auditor
The auditors, Deloitte LLP, have expressed their willingness to continue in office as auditor and appropriate
arrangements have been put in place for them to be deemed reappointed as auditor pursuant to sections 485 – 488
of the Companies Act 2006.
Approved by the Board and signed on its behalf by:
I T Lowitt
Director
29 March 2017
Marex Spectron Group Limited
8
DIRECTORS’ RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Annual Report and Financial Statements in accordance with
applicable law and regulations. Company law requires the directors to prepare financial statements for each
financial year. Under that law the directors have elected to prepare the financial statements in accordance with
International Financial Reporting Standards (‘IFRSs’) as adopted by the European Union. In accordance with
company law, the directors must not approve the financial statements unless they are satisfied that they give a true
and fair view of the state of affairs of the Group and Company and of the profit or loss of the Group and Company
for that period.
In preparing these financial statements, International Accounting Standard (‘IAS’) 1 requires directors to:
▪ properly select and apply accounting policies;
▪ present information, including accounting policies, in a manner that provides relevant, reliable,
comparable and understandable information;
▪ provide additional disclosures when compliance with the specific requirements in IFRSs are
insufficient to enable users to understand the impact of particular transactions, other events and
conditions on the Group and Company’s financial position and financial performance; and
▪ make an assessment of the Group and Company’s ability to continue as a going concern.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the
Group and Company’s transactions and disclose with reasonable accuracy at any time the financial position of the
Group and Company and enable them to ensure that the financial statements comply with the Companies Act 2006.
They are also responsible for safeguarding the assets of the Group and Company and, hence, for taking reasonable
steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the corporate and financial information included
on the Company’s website. Legislation in the United Kingdom governing the preparation and dissemination of
financial statements may differ from legislation in other jurisdictions.
Marex Spectron Group Limited
9
STRATEGIC REPORT
Review of financial performance
2016 was a record year for the firm with highest Operating Profit and Profit Before Tax (‘PBT’). The positive
earnings trajectory over the past four years is apparent in almost all the metrics, but particularly PBT (excluding
one-time revenues) which excludes gains on Eclipse sale in 2014 and sale of LCH shares in 2013. PBT (excluding
one-time revenues) was $27 million in 2016, almost $10 million more than 2015 and $35.5 million above 2013:
2016
$ million
2015
$ million
2014
$ million
2013
$ million
2016
v 2015
$ million
Revenue 330.4 347.7 368.8 358.1 (17.3)
Expenses (304.1) (325.0) (353.7) (367.2) 20.9
Operating profit / (loss) 26.3 22.7 15.1 (9.1) 3.6
Net Financing (0.2) (1.2) (0.5) 0.6 1.0
Profit / (loss) before tax /
(before one-time
expenses)
26.1
21.5
14.6
(8.5)
4.6
One-time expenses 0.9 (3.9) (1.3) - 4.8
Profit / (loss) before tax /
(before one-time
revenues)
27.0
17.6
13.3
(8.5)
9.4
One-time revenues - - 9.3 2.3 -
Profit / (loss) before tax 27.0 17.6 22.6 (6.2) 9.4
In addition to the Statutory Account numbers, management also focuses on key performance indicators (‘KPIs’)
including Adjusted PBT and Adjusted Earnings Before Income Tax Depreciation and Amortisation (‘Adjusted
EBITDA’) which reflect the underlying profitability of the business by excluding specific one-time items and
impact of investments and cost to exit businesses. In 2016, Adjusted PBT was $32.4 million, $10 million above
2015 and $38 million above 2013. In 2016, management was able to renegotiate the dilapidation expenses in
relation to the exit of Copthall Avenue and Grosvenor Place premises reversing the prior year provisions; the
Group also incurred run-off costs following the closure of Securities and Easyscreen ($1.8 million) and investment
in new initiatives ($2.8 million) which, despite lowering current year earnings, form the platform for future growth.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
10
Review of financial performance (continued)
2016
$ million
2015
$ million
2014
$ million
2013
$ million
2016
v 2015
$ million
Profit / (loss) before
tax (reported) 27.0 17.6 22.6 (6.2) 9.4
Exclude:
One-time revenue - - 9.3 - -
One-time expenses 0.9 (3.9) (1.3) (0.5) 4.8
Renegotiated
dilapidations (0.9) - - - (0.9)
Exiting Securities
and Easyscreen (1.8) - - - (1.8)
Investments in new
initiatives (2.8) - - - (2.8)
Owner fees (0.8) (0.7) (1.5) (0.5) (0.1)
Adjusted profit / (loss)
before tax
32.4
22.2
16.1
(5.2)
10.2
Similarly, Adjusted EBITDA was a record $37.1 million, up $6 million on 2015 and $26 million on 2013:
2016
$ million
2015
$ million
2014
$ million
2013
$ million
2016
v 2015
$ million
Adjusted profit / (loss)
before tax 32.4 22.2 16.1 (5.2) 10.2
Exclude:
Depreciation &
amortisation (2.9) (4.7) (6.5) (9.3) 1.8
Financing costs (1.8) (1.8) (0.9) - -
Other non-operating costs - (2.3) (1.3) (7.2) 2.3
Adjusted EBITDA 37.1 31.0 24.8 11.3 6.1
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
11
Review of financial performance (continued)
Typically for a commodity broker, increasing commodity prices and high volatility have a positive impact on
performance. Over the past four years, as earnings have been improving, markets have not been helpful. Over the
period 2010-15 the Bloomberg Commodity Index declined 51%. The index improved by 11% in 2016, and while it
is premature to ‘call the bottom’, improving prices would help our clients and our business.
Bloomberg Commodity Index (BCOM)
Year-end points:
Similarly, volatility over the past four years has been below the long term average. In 2016, despite spikes
following the UK’s referendum on EU membership (‘BREXIT’) and the US election, average volatility level for
the year was 5% lower than 2015 (but above the level of 2013-14):
VIX Index
Average for the year:
89
110
135 146
171 167
185
117
139
162
141 139 126
104
79 88
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Bloomberg Commodity
Index (BCOM)
Yead-end points -51%
+11%
25.7 27.3
22.0
15.5 12.8 12.8
17.5
32.7 31.5
22.5 24.2
17.8
14.2 14.2 16.7 15.8
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
VIX Index
Average for year
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
12
Review of financial performance (continued)
Business review
The Group is organised into four business segments across three geographic regions. Management evaluates the
Group’s performance on a Net Revenue basis – i.e. Gross Revenue (see note 5 to the Financial Statements) less
Cost of Trade. On this basis, and excluding closed businesses, the Group generated Net Revenue of $242 million,
$1.7 million below 2015; on an FX neutral basis, excluding the impact of lower GBP / USD rate, Net Revenue was
$3 million above 2015:
31 December 2016
Europe
$ million
North
America
$ million
Asia
$ million
Total
$ million
Commodities 147.0 39.0 16.2 202.2
Futures and Securities 13.5 6.2 - 19.7
Market Access 15.8 - - 15.8
Other 3.7 0.6 - 4.3
180.0 45.8 16.2 242.0
Closed businesses* 1.1 - - 1.1
Revenue 181.1 45.8 16.2 243.1
31 December 2015
Europe
$ million
North
America
$ million
Asia
$ million
Total
$ million
Commodities 152.3 36.7 13.8 202.8
Futures and Securities 15.7 5.0 - 20.7
Market Access 18.8 - - 18.8
Other 0.8 0.7 - 1.5
187.6 42.4 13.8 243.8
Closed businesses* 7.2 - - 7.2
Revenue 194.8 42.4 13.8 251.0
*Closed businesses include Securities and Easyscreen.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
1 Market share is calculated as Marex volumes as a percentage of externally sourced total market volume information
13 2 External source: Combination of Intercontinental Exchange (‘ICE’) and Chicago Mercantile Exchange (‘CME’)
3 External source: The London Energy Brokers Association (‘LEBA’)
4 External source: CME
Review of financial performance (continued)
Business review (continued)
Commodities
31 December 2016
Europe
$ million
North
America
$ million
Asia
$ million
Total
$ million
Commodities
Energy 78.7 31.0 5.7 115.4
Metals 40.9 4.8 10.6 56.3
Agriculture 27.4 3.2 - 30.6
Commodities revenue 147.0 39.0 16.3 202.3
31 December 2015
Europe
$ million
North
America
$ million
Asia
$ million
Total
$ million
Commodities
Energy 83.1 29.3 5.2 117.6
Metals 42.0 4.3 8.6 54.9
Agriculture 27.2 3.1 - 30.3
Commodities revenue 152.3 36.7 13.8 202.8
Energy
Energy Net Revenues were $2.1 million down on 2015 (-1.7%), with growth in North America and Asia offset by a
decline in Europe. The reduction in European markets was primarily due to lower GBP / USD rate.
The business leading market share was maintained and the firm continued to be top three in the following key
products.
Product Market Share1 Rank
European Fuel Oil 31%2 Number 1
Natural Gas (NBP) 29%3 Top 3
UK & European Power 17%3 Top 3
New York Ethanol 46%3 Number 1
Chicago Ethanol 20%4 Top 3
The majority of the investments undertaken by the Group in 2016 were in Energy, and largely in North America.
The OTC Energy market in North America is estimated to be as large as European markets, and our long-term aim
is to have a North American business of similar size to Europe: the initiatives in Canadian Physical Crude, Houston
Light Ends and US Power are key steps towards this goal. There have also been investments in Europe and Asia,
mainly in Financial Gasoline, Freight and Light Ends.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
5 Market share is calculated as Marex volumes as a percentage of externally sourced total market volume information
146 External source: ICE
7 External source: Euronext
Review of financial performance (continued)
Business review (continued)
Commodities (continued)
Metals
Metals Net Revenues were $1.3 million above 2015 (+2.4%), despite the decline in LME volumes (down 8%)
which indicates our growing market share and competitiveness.
The Group has maintained its market leader position on the LME with a share of 20% of total volumes and 22% of
LME electronic platform (LME Select).
As banks continue to withdraw from the Metals market, or limit their involvement, we see opportunities to provide
services to institutional clients and have evolved our offering to serve this segment.
Agriculturals
Business Net Revenues were flat, with record level broking commission offset by lower market making. The
Group is a market leader in options markets:
Product Market Share5 Rank
London/NY Cocoa Options 36%6 Top 2
London/NY Coffee Options 22%6 Top 2
London/NY Sugar Options 11%6 Top 3
European Grains 24%7 Top 2
Futures and Securities, and Market Access
FF&O
Net Revenues for 2016 were $15.9 million, in line with last year, with increased contribution from North American
desks offsetting a reduction in Europe. Market conditions improved in the second part of the year. In 2016, the
Group restructured a few underperforming desks and hired a high quality team in anticipation of an improving
macro environment for this business.
ProTrader
2016 was a challenging year for ProTrader as it was for the entire industry. These markets were impacted by a
flattening yield curve and central bank forward guidance limiting short term trading opportunities and the
continued uncertainty around MiFID II.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
15
Review of financial performance (continued)
Balance sheet
Shareholders’ equity grew by $0.2 million following the net effect of profit after tax of $20.5 million (2015: $17.6
million), dividend payments made to shareholders of $20.0 million (2015: $nil) and the reduction in value of
available-for-sale assets (net of deferred tax) of $0.3 million (2015: $1.3 million). Since 2011, tangible equity has
increased by $47.9 million (26%). Since 2013, this has added $39.7 million (20.5%) to tangible equity compared
to $8.3 million (4.5%) from 2011 to 2013.
2016
$ million
2015
$ million
2014
$ million
2013
$ million
2012
$ million
2011
$ million
Shareholders’ equity 373.8 373.6 357.3 338.8 345.4 331.6
Goodwill (141.0) (141.0) (144.0) (145.6) (145.6) (146.7)
Tangible equity 232.8 232.6 213.3 193.2 199.8 184.9
2016 2015
$ million Assets Liabilities Assets Liabilities
Cash and cash equivalents 188.2 - 158.3 -
Financial instruments – held to maturity
(Treasuries) 120.2 - 119.5 -
Warrant inventory - - 15.9 -
Repurchase agreements - - - (18.9)
Short term borrowings - (40.0) - -
Liquid resources 308.4 (40.0) 293.7 (18.9)
Trade receivables 622.9 - 634.9 -
Other receivables 23.4 - 13.5 -
Trade payables - (647.3) - (632.8)
Other payables - (60.3) - (74.0)
Trade and other receivables / (payables) 646.3 (707.6) 648.4 (706.8)
Financial instruments 24.0 (12.0) 4.9 (3.5)
Matched principal broking (FX and bullion) 24.0 (12.0) 4.9 (3.5)
Net tax liabilities - (1.3) - (2.4)
Provisions - (0.3) - (1.4)
Non-current assets 15.3 - 18.6 -
Other 15.3 (1.6) 18.6 (3.8)
994.0 (761.2) 965.6 (733.0)
Tangible equity 232.8 232.6
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
16
Review of financial performance (continued)
Balance sheet (continued)
Overall, total assets on the balance sheet have increased by $28.3 million (3%) year-on-year. Trade payables,
representing client activity grew $14.5 million (2%) from $632.8 million to $647.3 million as at 31 December
2016. Trade receivables, mainly driven by margin requirements with exchanges reduced as the Group posted $12.0
million (1%) less collateral from $634.9 million to $622.9 million at the year end.
Deployment of equity
The Group’s liquid resources have decreased by $6.4 million (2%) from $274.8 million to $268.4 million as at 31
December 2016. Cash and cash equivalents have increased by $29.9 million (19%) year-on-year with the Group
utilising $35.0 million (2015: $nil) of the available credit facility and $5 million (2015: $nil) of bank overdraft
facilities at the year end. While the total US Treasuries are flat year-on-year the Group had no repurchase
agreements as at 31 December 2016 (2015: $18.9 million). The Group purchased $15.9 million of warrant
inventory as at 31 December 2015 which was delivered in the first week of 2016. Net financial instruments have
increased by $10.6 million with other net payables down $21.1 million (46%) year-on-year.
2016
$ million
2015
$ million
2014
$ million
2016 v 2015
$ million
2016 v 2015
%
Cash and cash equivalents 188.2 158.3 159.1 29.9 19%
Financial instruments –
held to maturity
(Treasuries) 120.2 119.5 120.0 0.7 -
Warrant inventory - 15.9 - (15.9) (100%)
Repurchase agreements - (18.9) - 18.9 (100%)
Short term borrowings (40.0) - (25.0) (40.0) -
Liquid resources 268.4 274.8 254.1 (6.4) (2%)
Trade receivables 622.9 634.9 542.7 (12.0) (2%)
Trade payables (647.3) (632.8) (698.2) (14.5) 2%
Net trade (payables) /
receivables
(24.4)
2.1
(155.5)
(26.5)
(1,262%)
Financial instruments –
assets 24.0 4.9 12.2 19.1 390%
Financial instruments –
liabilities (12.0) (3.5) (10.3) (8.5) (243%)
Matched principal
broking / (FX and
bullion)
12.0
1.4
1.9
10.6
757%
Other receivables 23.4 13.5 15.7 9.9 73%
Other payables (60.3) (74.0) (66.4) 13.7 (19%)
Net tax liabilities (1.3) (2.4) (6.6) 1.1 (46%)
Provisions (0.3) (1.4) (1.2) 1.1 (79%)
Non-current assets 15.3 18.6 20.0 (3.3) (18%)
Other net payables (23.2) (45.7) (38.5) 22.5 (49%)
Tangible equity 232.8 232.6 62.0 0.2 -
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
17
Review of financial performance (continued)
Balance sheet (continued)
Liquidity
In addition to cash and unencumbered US Treasuries, the firm includes warrants in its liquid resources as the Group
is able to convert these to cash on a trade date plus one-day basis. In addition, forward profits on LME, included in
trade receivables, are also a source of liquidity. These arise from closed-out house positions that are in the money,
but the cash is not received until the position finally settles. The firm is able to utilise these profits as part of its
collateral requirements at the LME or, if in excess to requirements, they can be sold or factored.
Group Liquidity Resource is a measure of the extent to which the Group has cash or assets that can be quickly
converted to meet immediate and short-term obligations. Group liquidity resources consist of non-segregated cash,
unencumbered US Treasuries, House LME warrant inventory, and House LME forward profits in excess of margin
requirements. Group Liquidity Resources were $218 million at 31 December 2016 (2015: $241 million). Average
Liquidity Resources in 2016 were $202 million (2015: $213 million). Considering just Cash and Unencumbered
US Treasuries, the 2016 average was $191 million (2015: $191 million); holding liquidity in the form of warrants
on forward profits is, as evidenced by the difference, relatively modest. The increase in average Liquidity
Resources was driven by continued profitability of the Group; somewhat lower Exchange Default Fund
requirements (2016: average of $42 million; 2015: average of $38 million); and, most importantly, higher LME
aggregation benefit (quantity of longs and shorts within the LME portfolio).
Regulatory capital
The Group has maintained its strong capital base throughout the year as well as at the balance sheet date.
As at 31 December 2016, the Group had a total minimum capital requirement (‘Pillar 1’) of $87.6 million (2015:
$70.4 million) and capital resources of $211.9 million (2015: $211.7 million) equating to an excess of $124.3
million (2015: $141.3 million), total capital ratio of 19.34% (2015: 24.04%) and a solvency ratio of 242% (2015:
301%).
The average capital requirement for the year was $91.5 million (2015: $92.0 million), supported by $211.7 million
(2015: $209.5million) of regulatory capital resources and, therefore, the average surplus was $120.2 million (2015:
$117.5 million).
Return on assets
The return on assets, as required by Article 90 of the Capital Requirements Directive, as at 31 December 2016 is
7% (2015: 6%). The return on assets reflects the Company’s operating profit of $26.3 million (2015: $22.7
million) as a percentage of the net assets $373.8 million (2015: $373.6 million).
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
18
Overview of risk management
Excellence in risk management is at the core of Marex Spectron’s business operations. The Group has stringent
risk management procedures and well-established risk management processes. Marex Spectron views risk
management as a key factor in delivering its strategic business aims and objectives whilst ensuring its long-term
sustainability and effective corporate governance.
Business strategy, risk strategy and risk appetite are all aligned to ensure that decision making across the Group
reflects the correct approach to risk. By taking into account the risks posed across each of the business lines, the
effective management of capital and liquidity within Marex Spectron is optimised. The Marex Spectron Enterprise
Wide Risk Management (‘EWRM’) framework sets out the risk management approach and consists of the
following eight key components:
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
19
Overview of risk management (continued)
Governance structure
Marex Spectron’s risk governance model underpins how the risk management structure is directed across the
Group.
In pursuit of effective risk governance, a ‘Three Lines of Defence’ model has been adopted in conjunction with a
strong risk culture, good communication and understanding and a strong sense of risk awareness across the Group:
▪ the first line of defence covers the controls in place to deal with and manage the day-to-day risk
management within the business units, support functions and embedded operational risk staff;
▪ the second line of defence consists of the specialist control functions which make up the risk
management infrastructure of the Group; and
▪ the third line of defence is Marex Spectron’s internal audit function auditing and covering all aspects of
both the first and second lines of defence.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
20
Overview of risk management (continued)
Risk control and reporting framework
There is a clearly defined suite of risk tools, processes, policies and procedures in place that allow for the
successful monitoring and control of the risks of the Group and a clearly defined escalation and reporting process to
senior management and other key staff within the Group. The control framework consists of the following
components:
Risk policy framework
Marex Spectron’s policy framework sets out the rules and guidelines for drafting, approving, communicating,
implementing, embedding and monitoring compliance for all risk related policies across the Group. The policy
framework defines the key policies necessary to manage all risks arising within each risk category across the Group
and aims to deliver a focused and consistent enterprise wide view of risk. Specific policies and procedures have
been implemented to address each of the principal risks, see below. The process and methodology for addressing
each risk may differ depending on the relevant business unit.
The policy framework sets the minimum standards for how each risk is:
▪ identified – the method used to identify risk exposures;
▪ measured – how the likelihood, severity and impact / quantum of those risks is measured;
▪ managed – how minimum standards are set to manage the risks;
▪ controlled – the controls in place to help mitigate the risks;
▪ reported – how the risks are communicated, reported, and escalated; and
▪ assured – how the risk management process is overseen by an independent function
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
21
Overview of risk management (continued)
Internal audit
Marex Spectron has an internal audit function and this represents the Group’s third line of defence providing
independent assurance to senior management and the Board. The objectives of Internal Audit are to assess the
effectiveness of the Group’s risk management, internal controls and governance process; whether operational and
financial controls are appropriate and consistently applied; the effectiveness of internal controls for the
safeguarding of assets; the reliability and integrity of management information; and the adequacy of processes to
ensure compliance with applicable laws and regulations.
The Board’s assessment of the principal risks
The directors of the Group confirm that they have carried out a robust assessment of the principal risks facing the
Group, including those that would threaten its business model, future performance, solvency or liquidity.
The Group faces a variety of risks that are inherent in its normal course of business. These risks can be categorised
into: Financial; Operational; and Strategic and Business. The following are deemed to be the principal risks and
uncertainties that could affect Marex Spectron’s activities within each of these areas and are described, below,
along with how the Group seeks to manage or mitigate each of these risk exposures.
Financial risk
Liquidity risk
Liquidity is essential to Marex Spectron’s businesses. Liquidity risk is the risk that the Group either does not have
sufficient financial resources available to meet its obligations as they fall due or can only secure such resources at
excessive cost.
Liquidity risk is assessed and managed under the Individual Liquidity Adequacy Assessment (‘ILAA’) and
liquidity risk framework. The Group’s liquidity could be impaired by an inability to sell assets or unforeseen
outflows of cash or collateral. This situation may arise due to circumstances beyond Marex’s control. This
includes general market disruption, operational problems that affect third parties or the Group or from the
perception amongst market participants that the Group is experiencing greater liquidity risk.
Marex Spectron’s ability to sell assets may be further impaired if other market participants are seeking to sell
similar assets at the same time as is likely to occur in a liquidity or other market crisis. Given the Group’s
significant position on a number of exchanges and its market-maker role, there is an expectation that Marex
Spectron will continue to make a market in stress conditions.
To mitigate liquidity risk, the Group has implemented robust cash management policies and procedures that
monitor liquidity daily to ensure that Marex Spectron has sufficient resources to meet its margin requirements at
clearing houses and third party brokers. There are strict guidelines in relation to the products and product duration
into which excess liquidity can be invested.
Excess liquidity is invested in highly liquid instruments, such as cash deposits with financial institutions for a
period of less than three months and US Treasuries with a maturity of up to two years.
The financial liabilities are based upon rates set on a daily basis, (apart from Marex’s financing of warrants and the
credit facility, where the rates are set for the term of the loan and / or repo). For assets not marked-to-market, there
are no material differences between their carrying and fair value.
Marex Spectron has a varied client base that can hold both long and short positions in the same product. As a
significant market maker, the Group’s exchange exposure has, at any given point in time, some element of liquidity
offset or aggregation benefit.
In the event of a liquidity issue arising, the Group has recourse to existing global cash resources. Marex Spectron
also has a $15 million uncommitted overdraft facility and a $65 million committed revolving credit facility as
additional contingency funding.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
22
Overview of risk management (continued)
Financial risk (continued)
Credit risk
Credit risk is the risk that third parties who owe Marex Spectron money, securities or other assets fail to perform on
their contractual obligations. This situation may arise due to their lack of liquidity, bankruptcy, operational failure
as well as for other reasons. In addition, failure or concerns regarding a default by an institution could lead to
significant liquidity problems, losses or subsequent defaults of other institutions. This could adversely affect the
Group, given the commercial soundness of many financial institutions may be closely related as a result of clearing,
credit, trading or other relationships between institutions.
Marex Spectron is exposed to credit risk arising from a number of sources, including:
▪ the temporary credit exposure that arises from the timing of margin payments, where the Group
delivers margin to a clearing house before receiving the matching payment either from a non-credit
client or from a credit client from whom margin has been called since the credit limit has been
exceeded;
▪ the extension of credit to clients in relation to initial and variation margin payments;
▪ settlement risk arising from the release of currency or warrants prior to settlement by the counterparty –
given that most settlement is on a delivery-versus-payment basis, this is mainly confined to a small
number of trades in LME warrants with the most creditworthy counterparties; and
▪ exposure to non-client counterparties, including exchanges, clearing houses or deposit-taking
institutions holding assets of the Group, including exchange memberships, default fund contributions
and cash deposits.
This risk is mitigated by the robust client approval process, the taking of collateral and the continual and real time
monitoring of clients / counterparties and their exposures. Most clients are required to pre-fund their obligations to
Marex, but a subset are granted credit facilities following detailed qualitative and quantitative analysis and approval
by the Group’s Credit Committee and, if necessary, the Board Risk Committee. Concentrations of risk are
carefully monitored and controlled, whether they are the result of a single client or counterparty, geography, sector,
market or product and remedial action is taken where either a risk appetite level is approached / breached or where
considered necessary for other reasons.
Market risk
Market risk is defined as the risk of loss that arises from fluctuations in the values of the Group’s traded positions
due to adverse changes in market prices, volatilities, interest rates and foreign exchange. It also includes the risks
that arise from open foreign exchange and interest rate positions on the Statement of Financial Position; for
example, via our cash and investment balances and bank borrowings.
Marex Spectron incurs market risk primarily as a result of taking positions in the course of its market-making
business. The Group generally aims to match buyers and sellers in the markets where it operates: the Group has a
relatively low appetite for intraday position risk, but in businesses such as Metals and Agricultural Commodities it
is necessary to augment market liquidity with firm liquidity.
Market risk can also arise in relation to client-driven trading where timing issues or market opening hours result in
the business carrying a position for a short period of time, typically overnight. Spread, outright and option risks
result from cash and derivative exposures in commodities, foreign exchange and financial products. Risks are
generally limited to highly liquid exchange-traded and foreign exchange contracts.
The Board has clearly defined its risk appetite for market risk and a variety of measurement methodologies,
including Value-at-Risk (‘VaR’), scenario analysis and stress testing are used to quantify and assess the levels of
market risk to which the Group is exposed. Positions can be managed or additional hedging instruments can be
acquired to ensure risk remains within the defined risk appetite.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
23
Overview of risk management (continued)
Financial risk (continued)
Market risk (continued)
Marex’s overall exposure to market risk is mitigated by its operation as an intermediary on most transactions. As
an intermediary, the Group aims to minimise its market risk by matching buyers and sellers. However, from time-
to-time, Marex will take the risk of a given trade onto its own books within pre-defined parameters and risk limits
which are monitored and controlled by the Risk Department.
Capital management
The primary objective of Marex Spectron’s capital management is to ensure that it maintains strong capital ratios in
order to support its business growth as well as to maximise shareholder value. The Group manages its capital
structure and makes adjustments to it in light of changes in economic conditions. In addition, Marex manages its
capital so that it complies with the requirements of the regulatory authorities, as well as ensuring its capital base is
adequate to cover the risks inherent in the business as defined in the Group’s Internal Capital Adequacy
Assessment Process (‘ICAAP’) document.
Operational risk
Operational risk is the risk of losses resulting from inadequate or failed internal processes, people, and systems or
from external events. It is inherent in all the products, activities, processes and systems. Therefore, managing
operational risk is considered the responsibility of all Group employees.
The Board recognises the business imperative to identify, assess, manage, mitigate and report operational risk. The
firm adopts a ‘Three Lines of Defence’ model, where each line of defence has specific roles and responsibilities in
the implementation of the Operational Risk Framework (‘ORF’). The Risk Function has the responsibility to
design, maintain and implement the ORF.
The Framework enables the directors to define the operational risk profile of the firm via the performance of
periodic risk assessments, the collection of loss data through internal risk event reporting systems and the
monitoring of the set of key risk indicators, ensuring the risk profile stays within the firm’s risk appetite.
All the framework’s components concur with the definition of the scenario analysis used in determining the
Group’s internal capital assessment for operational risk within its ICAAP.
Information security / cyber risk
Information security, data confidentiality, integrity and availability of information are of critical importance to our
businesses. Technology risk is inherent not only in the Group’s information technology assets, but also in the
people and processes that interact with them. Cyber risk, which is part of technology risk, is the risk that Marex
Spectron’s systems will not operate properly or will be compromised as a result of cyber-attacks, security breaches,
unauthorized access, loss, destruction or alteration of data, unavailability of service, computer viruses or other
events that could have an adverse security impact. As a result, the Group could be subject to litigation, suffer
financial loss not covered by insurance, experience disruption of businesses, liability to clients, regulatory
intervention or reputational damage.
Although Marex Spectron has business continuity plans, businesses face a wide variety of operational risks,
including technology risk arising from dependencies on information technology, third-party suppliers and the
worldwide telecommunications infrastructure. The increasing sophistication of cyber-attacks, means that a cyber-
attack is inherently unpredictable and could occur without detection for an extended period of time.
The Group maintains active links with peer associations and appropriate government agencies to keep abreast of
developments and has timely access to cyber threat intelligence. Service and infrastructure disruption risks are
managed through Marex’s business continuity management plan, the incident response plan, the operational risk
management program and other contingency and resiliency plans.
Marex Spectron Group Limited
STRATEGIC REPORT (CONTINUED)
24
Overview of risk management (continued)
Operational risk (continued)
Legal and compliance (continued)
Compliance or regulatory risk arises from a failure or inability to comply with the laws, regulations or codes
applicable specifically to the financial services industry. Non-compliance can lead to fines, public reprimands,
enforced suspensions of services or, in extreme cases, withdrawal of authorisation to operate.
Companies within the Group are subject to authorisation by the LME, the CME, ICE, the NYSE Euronext and
Eurex. Marex Spectron is regulated on a consolidated basis in the UK by the FCA, in the US by the NFA and
CFTC, in Hong Kong by the SFC, and in Singapore by the MAS and IES.
Legal risk can also arise through litigation or the failure of contractual documentation when relied upon. Litigation
risk is difficult to completely eliminate, but the Group mitigates this risk through its transparent and considered
approach to the activities which it undertakes. The failure of contractual documentation when relied upon is
mitigated by using market standard documents wherever possible and ensuring that bespoke or amended
documentation is thoroughly reviewed by the internal Legal Department and / or external counsel.
Strategic and business risk
This risk is defined as the impact of a change or a failure to change Marex Spectron’s business model which
impacts its ability to meet its strategic or financial objectives. It might arise from the pursuit of an unsuccessful
business plan, from making slow or poor business decisions, from the substandard execution of decisions, from
inadequate resource allocation, or from a failure to respond well to changes in the business environment.
The Group’s Board and Executive Committee regularly review Marex Spectron’s regulatory and business
environment, the performance and capital requirements of its business lines, the level of investment in new and
existing activities and its remuneration policy. The Group performs on-going surveillance of market trends, the
regulatory landscape and customer demand. This is supported by risk scenario contingency planning and the
assessment of emerging risks.
The directors, in preparing this strategic report, have complied with s414C of the Companies Act 2006.
I T Lowitt
Director
29 March 2017
25
INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF
MAREX SPECTRON GROUP LIMITED
We have audited the financial statements for Marex Spectron Group Limited for the year ended 31 December 2016
which comprise the consolidated income statement, the consolidated statement of other comprehensive income, the
statements of financial position, the statements of changes in equity, the cash flow statements and the related notes
1 to 35. The financial reporting framework that has been applied in their preparation is applicable law and
International Financial Reporting Standards (‘IFRSs’) as adopted by the European Union and, as regards the parent
company financial statements, as applied in accordance with the provisions of the Companies Act 2006.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those
matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company’s
members as a body, for our audit work, for this report, or for the opinions we have formed.
Respective responsibilities of directors and auditor
As explained more fully in the Directors’ Responsibilities Statement, the directors are responsible for the
preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility
is to audit and express an opinion on the financial statements in accordance with applicable law and International
Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices
Board’s Ethical Standards for Auditors.
Scope of the audit of the financial statements
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to
give reasonable assurance that the financial statements are free from material misstatement, whether caused by
fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Group’s and
the parent Company’s circumstances and have been consistently applied and adequately disclosed; the
reasonableness of significant accounting estimates made by the directors; and the overall presentation of the
financial statements. In addition, we read all the financial and non-financial information in the annual report to
identify material inconsistencies with the audited financial statements and to identify any information that is
apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the
course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we
consider the implications for our report.
Opinion on financial statements
In our opinion:
▪ the financial statements give a true and fair view of the state of the Group’s and of the parent
company’s affairs as at 31 December 2016 and of the Group’s profit for the year then ended;
▪ the Group financial statements have been properly prepared in accordance with IFRSs as adopted by
the European Union;
▪ the parent company financial statements have been properly prepared in accordance with IFRSs as
adopted by the European Union and as applied in accordance with the provisions of the Companies Act
2006; and
▪ the financial statements have been prepared in accordance with the requirements of the Companies Act
2006.
Opinion on other matter prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
▪ the information given in the Strategic Report and the Directors’ Report for the financial year for which
the financial statements are prepared is consistent with the financial statements; and
▪ the Strategic Report and the Directors’ Report have been prepared in accordance with applicable legal
requirements.
In the light of the knowledge and understanding of the company and its environment obtained in the course of the
audit, we have not identified any material misstatements in the Strategic Report and the Directors’ Report.
INDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OF
MAREX SPECTRON GROUP LIMITED (CONTINUED)
26
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report
to you if, in our opinion:
▪ adequate accounting records have not been kept by the parent company, or returns adequate for our
audit have not been received from branches not visited by us; or
▪ the parent company financial statements are not in agreement with the accounting records and returns;
or
▪ certain disclosures of directors' remuneration specified by law are not made; or
▪ we have not received all the information and explanations we require for our audit.
James Polson (Senior Statutory Auditor)
For and on behalf of Deloitte LLP
Chartered Accountants and Statutory Auditors
London, United Kingdom
29 March 2017
Marex Spectron Group Limited
27
CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2016
Notes
2016
$’000
2015
$’000
Revenue 5 330,370 347,747
Operating expenses (304,044) (325,021)
Operating profit 6 26,326 22,726
Other income 9 26 95
Other expense 9 876 (3,900)
Finance income 10 1,836 554
Finance expense 10 (2,057) (1,856)
Profit before taxation 11(b) 27,007 17,619
Tax 11(a) (6,515) 25
Profit after taxation 20,492 17,644
CONSOLIDATED STATEMENT OF OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2016
Notes
2016
$’000
2015
$’000
Profit after taxation 20,492 17,644
Other comprehensive income
Items that may be reclassified subsequently to profit or
loss when specific conditions are met
Loss on revaluation of investments – available-for-sale
(‘AFS’) 16(a) (365) (1,729)
Deferred tax on revaluation of investments – AFS 11(c), 25 104 379
Other comprehensive loss, net of tax (261) (1,350)
Total comprehensive income 20,231 16,294
All operations are continuing for the current and prior years.
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
28
STATEMENTS OF FINANCIAL POSITION
AS AT 31 DECEMBER 2016
Group Company
Notes
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Assets
Non-current assets
Goodwill 13 140,969 140,969 - -
Other intangible assets 14 537 771 46 -
Property, plant and equipment 15 2,501 3,779 - -
Investments – AFS 16(a) 6,896 7,261 3,134 3,165
Investments in subsidiaries 16(b) - - 331,722 331,722
Deferred tax 25 4,759 5,290 120 111
Other assets 18 - 908 - -
Subordinated loans due to group
undertakings 19 - - 17,500 9,000
Financial instruments – fair value
through profit or loss, pledged as
collateral 20 653 658 - -
Financial instruments – held to
maturity 21 12,500 40,936 - -
Financial instruments – held to
maturity, pledged as collateral 21 22,486 44,093 - -
Total non-current assets 191,301 244,665 352,522 343,998
Current assets
Inventory 17 - 15,870 - -
Derivative instruments 24 24,012 4,936 - -
Financial instruments – held to
maturity 21 23,564 9,999 - -
Financial instruments – held to
maturity, pledged as collateral 21 61,659 24,496 - -
Trade and other receivables 22 646,301 648,399 57 27,015
Corporation tax 322 1,095 - -
Cash and cash equivalents 188,178 158,261 486 116
Total current assets 944,036 863,056 543 27,131
Total assets 1,135,337 1,107,721 353,065 371,129
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
29
STATEMENTS OF FINANCIAL POSITION
AS AT 31 DECEMBER 2016 (CONTINUED)
Group Company
Notes
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Liabilities
Current liabilities
Derivative instruments 24 12,027 3,542 - -
Trade and other payables 26 707,580 706,750 1,877 839
Repurchase agreements - 18,938 - -
Short-term borrowings 23 40,000 - - -
Corporation tax 1,632 3,491 - 74
Provisions 27 265 1,413 - -
Total current liabilities 761,504 734,134 1,877 913
Total liabilities 761,504 734,134 1,877 913
Total net assets 373,833 373,587 351,188 370,216
Equity
Share capital 28 176,238 176,238 176,238 176,238
Share premium 29 134,301 134,286 134,286 134,286
Retained earnings 29 64,627 64,135 41,178 60,185
Revaluation reserve 29 (1,089) (828) (514) (493)
Other reserves 29 (244) (244) - -
Total equity 373,833 373,587 351,188 370,216
The Company reported a profit for year ended 31 December 2016 of $992,938 (2015: $48,495,000).
The financial statements on pages 27 to 85 were approved and authorised for issue by the Board of Directors on
21 March 2017 and signed on its behalf by:
I T Lowitt
Director
29 March 2017
Registration Number: 05613060
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
30
STATEMENT OF THE CHANGES IN EQUITY AND MOVEMENTS IN RESERVES
FOR THE YEAR ENDED 31 DECEMBER 2016
Group
Share
capital
$’000
Share
premium
$’000
Retained
earnings
$’000
Reval-
uation
reserve
$’000
Other
reserve
$’000
Total
$’000
At 1 January 2015 176,238 134,286 46,491 522 (244) 357,293
Profit for the period - - 17,644 - - 17,644
Loss on revaluation of
investments – AFS - - - (1,729) - (1,729)
Deferred tax on revaluation of
investments – AFS - - - 379 - 379
At 31 December 2015
and 1 January 2016
176,238
134,286
64,135
(828)
(244)
373,587
Profit for the period - - 20,492 - - 20,492
Loss on revaluation of
investments – AFS - - - (365) - (365)
Deferred tax on revaluation of
investments – AFS - - - 104 - 104
Capital contribution - 15 - - - 15
Dividends (note 12) - - (20,000) - - (20,000)
At 31 December 2016 176,238 134,301 64,627 (1,089) (244) 373,833
Company
Share
capital
$’000
Share
premium
$’000
Retained
earnings
$’000
Reval-
uation
reserve
$’000
Total
$’000
At 1 January 2015 176,238 134,286 11,690 757 322,971
Profit for the period (note 33) - - 48,495 - 48,495
Loss on revaluation of
investments – AFS - - - (1,562) (1,562)
Deferred tax on revaluation of
investments – AFS - - - 312 312
At 31 December 2015
and 1 January 2016
176,238
134,286
60,185
(493)
370,216
Profit for the period (note 33) - - 993 - 993
Loss on revaluation of
investments – AFS - - - (31) (31)
Deferred tax on revaluation of
investments – AFS - - - 10 10
Dividends (note 12) - - (20,000) - (20,000)
At 31 December 2016 176,238 134,286 41,178 (514) 351,188
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
31
CASH FLOW STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016
Group Company
Notes
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Profit before tax 27,007 17,619 1,014 48,345
Adjustment to reconcile profit
before tax to net cash flows:
Depreciation of property, plant and
equipment 6, 15 2,535 4,098 - -
Amortisation of other intangible assets 6, 14 389 606 - -
Impairment of subsidiaries 16(b) - - - 38,146
Impairment of Goodwill 9, 13 - 3,000 - -
Movement in financial instruments –
fair value through profit or loss 5 4 - -
Foreign exchange adjustment / on
other assets - 51 - -
(Decrease) / increase in provisions 27 (1,148) 210 - -
Interest received (1,210) (282) (320) (262)
Interest paid 1,964 1,721 - -
Operating cash flows before changes
in working capital
29,542
27,027
694
86,229
Working capital adjustments:
Decrease / (increase) in trade and other
receivables 2,098 (92,695) 26,958 (26,948)
Increase / (decrease) in trade and other
payables 206 148,357 992 (52,663)
Decrease / (increase) in inventory 15,870 (15,870) - -
(Increase) / decrease in derivative
instruments – assets (19,076) 7,246 - -
Increase / (decrease) in derivative
instruments – liabilities 8,485 (6,710) - -
Increase in financial assets – held to
maturity (685) (59,534) - -
Cash inflow from operating
activities
36,440
7,821
28,644
6,618
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
32
CASH FLOW STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
Group Company
Notes
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Corporation tax (paid) / received (6,342) 142 (94) (507)
Net cash inflow from operating
activities
30,098
7,963
28,550
6,111
Investing activities
Purchase of property, plant and
equipment 15 (1,257) (831) - -
Purchase of intangible assets 14 (155) (466) - -
Increase in investment in group
undertakings 16(b) - - - (7,305)
Net cash outflow from investing
activities
(1,412)
(1,297)
-
(7,305)
Financing activities
(Decrease) / increase in repurchase
agreements (18,938) 18,938 - -
Increase / (decrease) in short-term
borrowings 40,000 (25,000) - -
(Increase) / decrease in subordinated
loans to group undertakings - - (8,500) 1,000
Decrease in other assets 908 - - -
Interest received 1,210 282 320 262
Interest paid (1,964) (1,721) - -
Increase in capital contribution 15 - - -
Dividends paid (20,000) - (20,000) -
Net cash inflow / (outflow) from
financing activities
1,231
(7,501)
(28,180)
1,262
Net increase / (decrease) in cash and
cash equivalents
29,917
(835)
370
68
Cash and cash equivalents
Cash available on demand and short-
term deposits at 1 January 158,261 159,096 116 48
Increase / (decrease) in cash 29,917 (835) 370 68
Cash and cash equivalents
at 31 December
188,178
158,261
486
116
The notes on pages 33 to 85 form part of these financial statements.
Marex Spectron Group Limited
33
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016
1. GENERAL INFORMATION
Marex Spectron Group Limited (‘the Company’) is a company incorporated in England and Wales under the
Companies Act. The address of the registered office is 155 Bishopsgate, London EC2M 3TQ. The principal
activities of the Group and the nature of the Group’s operations are set out in note 5 and in the Strategic
Report.
The Group and company financial statements are presented in US Dollars (‘USD’) which is also the currency
of the primary economic environment in which the Group operates. Foreign operations are included in
accordance with the policies set out in note 3(k).
2. ADOPTION OF NEW AND REVISED STANDARDS
(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the
current year
In the current year, the Group has applied a number of amendments to IFRSs and a new Interpretation issued
by the International Accounting Standards Board (‘IASB’) that are mandatorily effective for an accounting
period that begins on or after 1 January 2016. Their adoption has not had any material impact on the
disclosures or on the amounts reported in these financial statements.
▪ Amendments to IFRS 10, IFRS 12 and IAS 28 Investment Entities
The Group has adopted the amendments to IFRS 10, IFRS 12 and IAS 28 Investment Entities: Applying the
Consolidation Exception for the first time in the current year. The amendments clarify that the exemption
from preparing consolidated financial statements is available to a parent entity that is a subsidiary of an
investment entity, even if the investment entity measures all its subsidiaries at fair value in accordance with
IFRS 10. The amendments also clarify that the requirement for an investment entity to consolidate a
subsidiary providing services related to the former’s investment activities applies only to subsidiaries that are
not investment entities themselves.
As the Company is not an investment entity (assessed based on the criteria set out in IFRS 10 as at 1 January
2016), the adoption of the amendments has had no impact on the disclosures or on the amounts recognised in
the Group’s consolidated financial statements.
▪ Amendments to IFRS 11 Accounting for Acquisitions of Interests in Joint Operations
The Group has adopted the amendments to IFRS 11 Accounting for Acquisitions of Interests in Joint
Operations for the first time in the current year. The amendments provide guidance on how to account for
the acquisition of a joint operation that constitutes a business as defined in IFRS 3 Business Combinations.
Specifically, the amendments state that the relevant principles on accounting for business combinations in
IFRS 3 and other standards should be applied. The same requirements should be applied to the formation of
a joint operation if and only if an existing business is contributed to the joint operation by one of the parties
that participate in the joint operation.
A joint operator is also required to disclose the relevant information required by IFRS 3 and other standards
for business combinations.
The adoption of these amendments has had no impact on the Group's consolidated financial statements.
▪ Amendments to IAS 1 Disclosure Initiative
The Group has adopted the amendments to IAS 1 Disclosure Initiative for the first time in the current year.
The amendments clarify that an entity need not provide a specific disclosure required by an IFRS if the
information resulting from that disclosure is not material, and give guidance on the bases of aggregating and
disaggregating information for disclosure purposes. However, the amendments reiterate that an entity should
consider providing additional disclosures when compliance with the specific requirements in IFRS is
insufficient to enable users of financial statements to understand the impact of particular transactions, events
and conditions on the entity’s financial position and financial performance.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
34
2. ADOPTION OF NEW AND REVISED STANDARDS (CONTINUED)
(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the
current year (continued)
▪ Amendments to IAS 1 Disclosure Initiative (continued)
In addition, the amendments clarify that an entity’s share of the other comprehensive income of associates
and joint ventures accounted for using the equity method should be presented separately from those arising
from the Group, and should be separated into the share of items that, in accordance with other IFRSs: (i) will
not be reclassified subsequently to profit or loss; and (ii) will be reclassified subsequently to profit or loss
when specific conditions are met.
The amendments also address the structure of the financial statements by providing examples of systematic
ordering or grouping of the notes.
▪ Amendments to IAS 16 and IAS 38 Clarification of Acceptable Methods of Depreciation and
Amortisation
The Group has adopted the amendments to IAS 16 and IAS 38 Clarification of Acceptable Methods of
Depreciation and Amortisation for the first time in the current year. The amendments to IAS 16 prohibit
entities from using a revenue-based depreciation method for items of property, plant and equipment. The
amendments to IAS 38 introduce a rebuttable presumption that revenue is not an appropriate basis for
amortisation of an intangible asset. This presumption can only be rebutted in the following two limited
circumstances:
▪ when the intangible asset is expressed as a measure of revenue; or
▪ when it can be demonstrated that revenue and consumption of the economic benefits of the
intangible asset are highly correlated.
As the Group already uses the straight-line method for depreciation and amortisation for its property, plant
and equipment and intangible assets, respectively, the adoption of these amendments has had no impact on
the Group's consolidated financial statements.
▪ Amendments to IAS 16 and IAS 41 Agriculture: Bearer Plants
The Group has adopted the amendments to IAS 16 and IAS 41 Agriculture: Bearer Plants for the first time in
the current year. The amendments define a bearer plant and require biological assets that meet the definition
of a bearer plant to be accounted for as property, plant and equipment in accordance with IAS 16, instead of
IAS 41. The produce growing on bearer plants continues to be accounted for in accordance with IAS 41.
The adoption of these amendments has had no impact on the Group’s consolidated financial statements as
the Group is not engaged in agricultural activities.
▪ Amendments to IAS 27 Equity Method in Separate Financial Statements
The Group has adopted the amendments to IAS 27 Equity Method in Separate Financial Statements for the
first time in the current year. The amendments focus on separate financial statements and allow the use of
the equity method in such statements. Specifically, the amendments allow an entity to account for
investments in subsidiaries, joint ventures and associates in its separate financial statements:
▪ at cost;
▪ in accordance with IFRS 9 (or IAS 39 for entities that have not yet adopted IFRS 9); or
▪ using the equity method as described in IAS 28 Investments in Associates and Joint Ventures.
The same accounting must be applied to each category of investments.
The amendments also clarify that when a parent ceases to be an investment entity, or becomes an investment
entity, it should account for the change from the date when the change in status occurs.
The adoption of the amendments has had no impact on the Company’s separate financial statements as the
Company accounts for investments in subsidiaries and associates at cost and is not an investment entity.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
35
2. ADOPTION OF NEW AND REVISED STANDARDS (CONTINUED)
(a) Amendments to IFRSs and the new Interpretations that are mandatorily effective for the
current year (continued)
▪ Annual Improvements to IFRSs 2012-2014 Cycle
The Group has adopted the amendments to IFRSs included in the Annual Improvements to IFRSs 2012-2014
Cycle for the first time in the current year.
The amendments to IFRS 5 introduce specific guidance in IFRS 5 for when an entity reclassifies an asset (or
disposal group) from held for sale to held for distribution to owners (or vice versa). The amendments clarify
that such a change should be considered as a continuation of the original plan of disposal and hence
requirements set out in IFRS 5 regarding the change of sale plan do not apply. The amendments also
clarifies the guidance for when held-for-distribution accounting is discontinued.
The amendments to IFRS 7 provide additional guidance to clarify whether a servicing contract is continuing
involvement in a transferred asset for the purpose of the disclosures required in relation to transferred assets.
The amendments to IAS 19 clarify that the rate used to discount post-employment benefit obligations should
be determined by reference to market yields at the end of the reporting period on high quality corporate
bonds. The assessment of the depth of a market for high quality corporate bonds should be at the currency
level (i.e. the same currency as the benefits are to be paid). For currencies for which there is no deep market
in such high quality corporate bonds, the market yields at the end of the reporting period on government
bonds denominated in that currency should be used instead.
The adoption of these amendments has had no effect on the Group’s consolidated financial statements.
(b) New and revised IFRSs in issue, but not yet effective
At the date of authorisation of these financial statements, the Group has not applied the following new and
revised IFRSs that have been issued, but are not yet effective and, in some cases, had not yet been adopted
by the EU:
IFRS 9 Financial Instruments
IFRS 15 Revenue from Contracts with Customers
IFRS 16 Leases
IFRS 2 (amendments) Clarification and Measurement of Share-based Payment Transactions
IAS 7 (amendments) Disclosure Initiative
IAS 12 (amendments) Recognition of Deferred Tax Assets for Unrealised Losses
IFRS 10 and IAS 28
(amendments)
Sale or Contribution of Assets between an Investor and its Associate or
Joint Venture
The directors do not expect that the adoption of the Standards listed above will have a material impact on the
financial statements of the Group in future periods, except as noted below:
▪ IFRS 9 will impact both the measurement and disclosures of financial instruments;
▪ IFRS 15 may have an impact on revenue recognition and related disclosures; and
▪ IFRS 16 will have a material impact on the reported assets, liabilities, income statement and
cash flows of the Group. Furthermore, extensive disclosures will be required by IFRS 16.
Beyond the information above, it is not practicable to provide a reasonable estimate of the effect of these
standards until a detailed review has been completed.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
36
3. SIGNIFICANT ACCOUNTING POLICIES
(a) Basis of accounting
The consolidated financial statements of the Group and the standalone financial statements of Marex
Spectron Group Limited have been prepared in accordance with International Financial Reporting Standards
(‘IFRS’) as issued by the International Accounting Standards Board (‘IASB’) as well as interpretations
issued by the IFRS Interpretations Committee (‘IFRIC’) as endorsed by the European Union (‘EU’).
The Company has taken the exemption in section 408(3) of the Companies Act 2006 not to present a
standalone income statement, standalone statement of comprehensive income and related notes that form a
part of the financial statements.
The financial statements have been prepared on the historical cost basis, except for the revaluation of certain
financial instruments that are measured at revalued amounts or fair values at the end of each reporting
period, as explained in the accounting policies below. Historical cost is generally based on the fair value of
the consideration given in exchange for goods and services.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date, regardless of whether that price is directly
observable or estimated using another valuation technique. In estimating the fair value of an asset or a
liability, the Group takes into account the characteristics of the asset or liability if market participants would
take those characteristics into account when pricing the asset or liability at the measurement date. Fair value
for measurement and/or disclosure purposes in these consolidated financial statements is determined on such
a basis, except for share-based payment transactions that are within the scope of IFRS 2, leasing transactions
that are within the scope of IAS 17, and measurements that have some similarities to fair value but are not
fair value, such as net realisable value in IAS 2 or value in use in IAS 36.
In addition, for financial reporting purposes, fair value measurements are categorised into Level 1, 2 or 3
based on the degree to which the inputs to the fair value measurements are observable and the significance of
the inputs to the fair value measurement in its entirety, which are described as follows:
▪ Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the
entity can access at the measurement date;
▪ Level 2 inputs are inputs, other than quoted prices included within Level 1, that are observable for the
asset or liability, either directly or indirectly; and
▪ Level 3 inputs are unobservable inputs for the asset or liability.
The principal accounting policies adopted are set out below.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
37
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(b) Basis of consolidation
The consolidated financial statements incorporate the financial statements of the Company and entities
controlled by the Company (‘its subsidiaries’) made up to 31 December each year. Control is achieved when
the Company:
▪ has the power over the investee;
▪ is exposed, or has rights, to variable return from its involvement with the investee; and
▪ has the ability to use its power to affect its returns.
The Company reassesses whether or not it controls an investee if facts and circumstances indicate that there
are changes to one or more of the three elements of control listed above.
Consolidation of a subsidiary begins when the Company obtains control over the subsidiary and ceases when
the Company losses control of the subsidiary. Specifically, the results of subsidiaries acquired or disposed of
during the year are included in the consolidated income statement from the date the Company gains control
until the date when the Company ceases to control the subsidiary.
Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting
policies used into line with the Group’s accounting policies.
All intragroup assets and liabilities, equity, income, expenses and cash flows relating to transactions between
the members of the Group are eliminated on consolidation.
(c) Going concern
The directors have, at the time of approving the financial statements, a reasonable expectation that the
Company and the Group have adequate resources to continue in operational existence for the foreseeable
future. Thus they continue to adopt the going concern basis of accounting in preparing the financial
statements.
(d) Business combinations
Acquisitions of subsidiaries and businesses are accounted for using the acquisition method. The
consideration transferred in a business combination is measured at fair value, which is calculated as the sum
of the acquisition-date fair values of assets transferred by the Group, liabilities incurred by the Group to the
former owners of the acquiree and the equity interest issued by the Group in exchange for control of the
acquiree. Acquisition-related costs are recognised in profit or loss as incurred.
At the acquisition date, the identifiable assets acquired and the liabilities assumed are recognised at their fair
value at the acquisition date, except that:
▪ deferred tax assets or liabilities and assets or liabilities related to employee benefit arrangements are
recognised and measured in accordance with IAS 12 Income Taxes and IAS 19 Employee Benefits
respectively; and
▪ assets (or disposal groups) that are classified as held for sale in accordance with IFRS 5 Non-current
Assets Held for Sale and Discontinued Operations are measured in accordance with that Standard.
Goodwill arises on the acquisition of subsidiaries and represents the excess of the cost of the acquisition
(including the fair value of deferred and contingent consideration) of a business combination, over the share
in the fair value of identifiable assets, liabilities and contingent liabilities acquired. Cost comprises the fair
values of assets given, liabilities assumed and equity instruments issued, plus any direct costs of acquisition.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
38
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(e) Goodwill
Goodwill is initially recognised and measured as set out above.
Goodwill has an indefinite useful economic life and is measured at cost less any accumulated impairment
losses. It is tested for impairment annually and whenever there is an indicator of impairment. Where the
carrying value exceeds the higher of the value in use or fair value less cost to sell, an impairment loss is
recognised in the income statement.
(f) Revenue recognition
Revenue is recognised when it is probable that the economic benefits will flow to the Group and the revenue
can be reliably measured. Revenue is measured at the fair value of the consideration received or receivable
taking into account any trade discounts and volume rebates granted by the Group.
Revenue comprises the following:
▪ execution and clearing commissions, which are recognised on a trade date basis;
▪ metals trading and broking, energy broking and foreign exchange trading activity where the Group acts
as principal, which is typically recognised on a fair value basis whereby movements in fair values of
the position are recognised in the income statement;
▪ desk facilities, licence and software fees, and market data fees which are recognised on an accruals
basis; and
▪ net interest directly relating to the trading activities of the Group are recognised on an accruals basis.
Other income primarily comprises exchange rebates and is recognised on an accruals basis.
In accordance with accepted practice, those financial instruments held for trading purposes are fair valued
and subsequent gains and losses are recognised in the income statement.
(g) Dividend income
Dividend income from investments is recognised when the shareholder’s rights to receive payment have
been established (provided that it is probable that the economic benefits will flow to the Group and the
amount of revenue can be measured reliably).
(h) Finance income and expense
Finance income is earned on balances held at exchanges, clearing houses, banks and brokers, and on
overdrawn client balances. Finance expenses are paid on overdrawn accounts with brokers and exchanges,
client and counterparty balances and short-term borrowings. Finance income and expenses are recognised on
an amortised cost basis using the effective interest rate (‘EIR’) method.
(i) Leases
Rentals payable under operating leases are charged to income on a straight-line basis over the term of the
relevant lease except where another more systematic basis is more representative of the time pattern in which
economic benefits from the lease asset are consumed.
In the event that lease incentives are received to enter into operating leases, such incentives are recognised as
a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-
line basis over the lease term, except where another systematic basis is more representative of the time
pattern in which economic benefits from the leased asset are consumed.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
39
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(j) Borrowing costs
Borrowing costs consist of interest and other costs that are incurred in connection with the borrowing of
funds and are expensed in the income statement over the period of the borrowing facility.
(k) Foreign currency translation
The Group and Company financial statements are presented in US Dollars (‘USD’), which is also the
currency of the primary economic environment (the functional currency) and the presentational currency of
the Group.
For each entity, the Group determines the functional currency and items included in the financial statements
of each entity are measured using that functional currency.
Transactions entered into by Group entities in a currency other than USD are recorded at the rates prevailing
when the transactions occur. Foreign currency monetary assets and liabilities are translated at the rates
prevailing at the reporting date. Exchange differences arising on the retranslation of monetary assets and
liabilities are similarly recognised immediately in the income statement.
On consolidation, the results of overseas operations are translated into USD at rates approximating to those
prevailing when the transactions took place. All assets and liabilities of overseas operations, including
goodwill arising on the acquisition of those operations, are translated at the rates ruling at the prevailing date.
(l) Employee benefits
Short-term employee benefits
Short-term employee benefits are expensed as the related service is provided. A liability is recognised for
the amount expected to be paid if the Group has a present legal or constructive obligation to pay this amount
as a result of past service provided by the employee and the obligation can be estimated reliably.
Retirement benefits: defined contribution schemes
The Group operates defined contribution schemes. Payments to defined contribution retirement benefit
schemes are recognised as an expense when employees have rendered services entitling them to
contributions.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
40
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(m) Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as
reported in the income statement because it excludes items of income or expense that are taxable or
deductible in other years and it further excludes items that are never taxable or deductible. The Group’s
liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the
balance sheet date.
Deferred tax
Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of
assets and liabilities in the financial statements and the corresponding tax bases used in the computation of
taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are
generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent
that it is probable that taxable profits will be available against which deductible temporary differences can be
utilised. Such assets and liabilities are not recognised if the temporary difference arises from the initial
recognition of goodwill or from the initial recognition (other than in a business combination) of other assets
and liabilities in a transaction that affects neither the taxable profit nor the accounting profit.
Deferred tax liabilities are recognised for taxable temporary differences arising on investments in
subsidiaries and associates, and interests in joint ventures, except where the Group is able to control the
reversal of the temporary difference and it is probable that the temporary difference will not reverse in the
foreseeable future. Deferred tax assets arising from deductible temporary differences associated with such
investments and interests are only recognised to the extent that it is probable that there will be sufficient
taxable profits against which to utilise the benefits of the temporary differences and they are expected to
reverse in the foreseeable future.
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent
that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to
be recovered.
Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled
or the asset is realised based on tax laws and rates that have been enacted or substantively enacted at the
balance sheet date. Deferred tax is charged or credited in the income statement, except when it relates to
items charged or credited in other comprehensive income, in which case the deferred tax is also dealt with in
other comprehensive income.
The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from
the manner in which the Group expects, at the end of the reporting period, to recover or settle the carrying
amount of its assets and liabilities.
Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax
assets against current tax liabilities and when they relate to income taxes levied by the same taxation
authority and the Group intends to settle its current tax assets and liabilities on a net basis.
Current tax and deferred tax for the year
Current and deferred tax are recognised in profit or loss, except when they relate to items that are recognised
in other comprehensive income or directly in equity, in which case, the current and deferred tax are also
recognised in other comprehensive income or directly in equity respectively. Where current tax or deferred
tax arises from the initial accounting for a business combination, the tax effect is included in the accounting
for the business combination.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
41
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(n) Property, plant and equipment
Property, plant and equipment are stated at cost, net of accumulated depreciation and any accumulated
impairment losses.
As well as the purchase price, cost includes the directly attributable costs and the estimated present value of
any future costs of dismantling and removing items. The corresponding liability is recognised within
provisions.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over
their useful lives, using the straight-line method, on the following bases:
Leasehold improvements over the remaining length of the lease or
20% per annum straight-line, where appropriate
Furniture, fixtures and fittings 20% to 50% per annum straight-line
Computer equipment 20% to 50% per annum straight-line
Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted if
appropriate.
An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits
are expected to arise from the continued use of the asset. The gain or loss arising on the disposal or
scrappage of an asset is determined as the difference between the sales proceeds and the carrying amount of
the asset and is recognised in the income statement.
(o) Other intangible assets
Internally generated intangible assets (software development costs)
Expenditure on internally generated intangible assets is only capitalised if it can be demonstrated that:
▪ it is technically feasible to develop the product for it to be available for use or sold;
▪ adequate resources are available to complete the development;
▪ there is an intention to complete and use or sell the product;
▪ the Group is able to use or sell the product;
▪ use or sale of the product will generate future economic benefits; and
▪ expenditure on the project can be measured reliably.
Capitalised development costs are measured at cost less any accumulated amortisation and any accumulated
impairment losses. Amortisation is calculated on a straight-line basis over estimated economic useful lives
of 2 to 5 years, which represents the period that the Group expects to benefit from using or selling the
products developed, and is recognised in the income statement.
The amount initially recognised for internally generated intangible assets is the sum of the expenditure
incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no
internally generated asset can be recognised development expenditure is recognised in profit and loss in the
period in which it is incurred.
Software licences
Software licences have a finite useful economic life of 2 to 5 years with the option of renewal at the end of
this period. They are amortised in the consolidated income statement on a straight-line basis over the period
of the licence.
An intangible asset is derecognised on disposal, or when no future economic benefits are expected from use
or disposal. Gains or losses arising from derecognition of an intangible asset, measured as the difference
between the net disposal proceeds and the carrying amount of the asset, are recognised in the consolidated
income statement when the asset is derecognised.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
42
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(p) Impairment of non-financial assets
Impairment tests on goodwill and other intangible assets with indefinite useful lives are undertaken annually.
Other non-financial assets are subject to impairment tests whenever events or changes in circumstances
indicate that their carrying amount may not be recoverable.
The recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that
reflects current market assessments of the time value of money and risks specific to the asset for which the
estimates of future cash flows have not been adjusted.
The impairment test is carried out on the asset’s cash generating unit (i.e. the smallest group of assets in
which the asset belongs for which there are separately identifiable cash flows).
An impairment loss in respect of goodwill is not reversed. For other assets, an impairment loss is reversed
only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been
determined, net of depreciation or amortisation, if no impairment loss had been recognised.
Where the carrying value of an asset exceeds its recoverable amount an impairment loss is recognised in the
income statement.
(q) Financial instruments
Financial assets and financial liabilities are recognised in the Group’s balance sheet when the Group
becomes a party to the contractual provisions of the instrument.
Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are
directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial
assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly
attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are
recognised immediately in profit or loss.
Effective interest method
The effective interest rate method is a method of calculating the amortised cost of a financial instrument and
allocating interest income or expense over the relevant period. The effective interest rate (‘EIR’) is the rate
that exactly discounts estimated future cash receipts (including all fees and points paid or received that form
an integral part of the effective interest rate, transaction costs and other premiums or discounts) through the
expected life of the financial instrument, or, where appropriate, a shorter period, to the net carrying amount
on initial recognition.
Financial assets
All financial assets are recognised and derecognised on a trade date where the purchase or sale of a financial
asset is under a contract whose terms require delivery of the financial asset within the timeframe established
by the market concerned, and are initially measured at fair value, plus transaction costs, except for those
financial assets classified as at fair value through profit or loss, which are initially measured at fair value.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
43
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(q) Financial instruments (continued)
Financial assets (continued)
Income is recognised on an effective interest basis for debt instruments other than those financial assets
classified as at fair value through profit or loss (‘FVTPL’).
Financial assets are classified into the following specified categories depending on the nature and purpose of
the financial assets and is determined at the time of initial recognition.
▪ Fair value through profit or loss: this category includes financial assets held for trading. They are
carried in the balance sheet at fair value with changes in fair value recognised in the income statement.
▪ Loans and receivables: these assets are non-derivative financial assets with fixed or determinable
payments that are not quoted in an active market. They arise principally through the provision of
goods and services to customers (‘trade debtors’), but also incorporate other types of contractual
monetary assets. They are carried at amortised cost using the EIR method less provision for any
impairment.
▪ Available-for-sale: these assets comprise the Group’s strategic investments in entities not qualifying as
subsidiaries, associates or jointly controlled entities, and investments in memberships, seats and
interests in investment exchanges. They are carried at fair value with changes in fair value recognised
in other comprehensive income. Fair values of quoted investments are based on current prices. If the
market for a financial asset is not active and for unlisted securities, the Group establishes fair value by
using the latest available trade price adjusted as necessary to reflect current market conditions.
▪ Held to maturity: held to maturity investments are financial assets with fixed or determinable payments
and fixed maturities where the Group has the intention and ability to hold to maturity. These assets are
measured at amortised cost, using the effective interest method less any impairment. The amortisation
is included in the income statement.
Derecognition of financial assets
The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset
expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the
asset to another entity.
Financial liabilities
Financial liabilities are classified as either financial liabilities at ‘FVTPL’ or ‘other financial liabilities’.
The Group classifies its financial liabilities into the following categories, depending on the purpose for
which the liability was assumed. The Group’s accounting policy for each category is as follows:
▪ Fair value through profit or loss (‘FVTPL’): this category includes financial instruments held for
trading. They are carried in the balance sheet at fair value with changes in fair value recognised in the
income statement.
▪ Other financial liabilities: other financial liabilities include the following items:
▪ trade and other payables and other short-term monetary liabilities which are recognised at
amortised cost; and
▪ bank borrowings, such interest-bearing liabilities are subsequently measured at amortised cost
using the EIR method, which ensures that any interest expense over the period to repayment is
recognised at a constant rate on the balance of the liability carried in the statement of financial
position.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
44
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(q) Financial instruments (continued)
Derecognition of financial liabilities
A financial liability is derecognised when the obligation under the liability is discharged, cancelled or
expires. In circumstances where a financial liability is replaced by the same lender yet the contractual terms
are substantially different or modified, the original financial liability will be derecognised at the point of
contractual exchange and the new financial liability recognised.
Offsetting of financial assets and liabilities
Financial assets and liabilities are offset and the net amount is reported in the statement of financial position
if there is a currently enforceable legal right to offset the recognised amounts and there is an intention and
ability to settle on a net basis, or to realise the assets and liabilities simultaneously.
Specific instruments
▪ Secured payables under repurchase agreements
When the Group sells a financial asset and simultaneously enters into an agreement to repurchase the same
or a similar asset at a fixed price on a future date (a repurchase agreement), the arrangement is accounted for
as borrowings and recognised in the statement of financial position as a payable under a repurchase
agreement. The underlying asset continues to be recognised in the Group’s financial statements.
Secured payables under repurchase agreements are subsequently measured at amortised cost.
▪ Derivative instruments
Derivative assets and derivative liabilities at fair value through profit or loss comprise of over-the-counter
foreign exchange and precious metal contracts. These are entered to hedge over-the-counter foreign
exchange and precious metal contracts transacted between the Group and their customers.
▪ Inventories
The Group holds physical metal, in the form of London Metal Exchange warrants. Inventories are held for
trading with the purpose of selling in the near term and carried at fair value with the changes in fair value
recognised in the consolidated income statement.
(r) Impairment of financial assets
The Group assesses at each reporting date, whether there is objective evidence that a financial asset or group
of financial assets, other than those at fair value through profit or loss, are impaired. An impairment exists if
one or more events that has occurred since initial recognition of the financial asset (an incurred ‘loss event’),
has an impact on the estimated future cash flows of the financial asset or group of financial assets that can be
reliably measured.
For listed and unlisted equity investments classified as available-for-sale, a significant or prolonged decline
in the fair value of the security below its cost is considered to be objective evidence of impairment.
When an available-for-sale asset is considered to be impaired, cumulative gains or losses previously
recognised in other comprehensive income are reclassified to profit or loss in the period.
For all other financial assets, objective evidence of impairment could include:
▪ debtors or a group of debtors experiencing significant difficulties, or there is high probability they will
enter bankruptcy;
▪ default or delinquency in interest or principal payments; and / or
▪ significant financial difficulty of the issuer or counterparty.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
45
3. SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
(s) Provisions
Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past
event, it is probable that the Group will be required to settle that obligation and a reliable estimate can be
made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present
obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the
obligation.
When some or all of the economic benefits required to settle a provision are expected to be recovered from a
third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received
and the amount of the receivable can be measured reliably.
Onerous contracts
Present obligations arising under onerous contracts are recognised and measured as provisions. An onerous
contract is considered to exist where the Group has a contract under which the unavoidable costs of meeting
the obligations under the contract exceed the economic benefits expected to be received under it.
(t) Cash and cash equivalents
Cash and cash equivalents in the statement of financial position comprise cash at banks and on hand, and
short-term deposits.
(u) Cash and non-cash distributions
The Company recognises a liability to make cash or non-cash distributions to its equity holders when the
distribution is authorised and the distribution is no longer at the discretion of the Company. As per the
corporate laws in the United Kingdom, a distribution is authorised when it is approved by the shareholders.
A corresponding amount is recognised directly in equity.
Non-cash distributions are measured at the fair value of the assets to be distributed with fair value re-
measurement recognised directly in equity. Upon distribution of non-cash assets, any difference between the
carrying amount of the liability and the carrying amount of the assets distributed is recognised in the
consolidated income statement.
(v) Client money
As required by the UK FCA’s Client Assets Sourcebook (‘CASS’) rules and the CFTC’s client money rules,
the Group maintains certain balances on behalf of clients with banks, exchanges, clearing houses and brokers
in segregated accounts. These amounts and the related liabilities to clients, whose recourse is limited to
segregated accounts, are not included in the statement of financial position as the Group is not beneficially
entitled thereto.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
46
4. CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS
In the application of the Group’s accounting policies, which are described in note 3, the directors are
required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities
that are not readily apparent from other sources. The estimates and associated assumptions are based on
historical experience and other factors that are considered to be relevant. Actual results may differ from
these estimates.
The estimates and underlying assumptions are reviewed on an on-going basis and revisions to accounting
estimates are recognised in the period in which the estimate is revised. Significant judgement and estimates
are necessary in relation to the following matters:
(a) Impairment of non-financial assets
The Group’s impairment testing for goodwill and non-financial assets with indefinite useful lives is based on
the fair value less costs of disposal. The fair value less costs of disposal calculation is based on available
data from similar assets or observable market prices less incremental costs for disposing of the assets and is
estimated by using the EBITDA multiples derived from adjusting comparative peer multiples. This multiple
is applied to the most recent Board approved financial budgets.
(b) Fair value of financial instruments
The Group determines the fair value of financial instruments that are not quoted, based on estimates using
present values or other valuation techniques. Those techniques are significantly affected by the assumptions
used, including discount rates and estimates of future cash flows. Where market prices are not readily
available, fair value is either based on estimates obtained from independent experts or quoted market prices
of comparable instruments. In that regard, the derived fair value estimates cannot be substantiated by
comparison with independent markets and, in many cases, may not be capable of being realised immediately.
(c) Useful lives of intangible assets and property, plant and equipment
Intangible assets and property, plant and equipment are amortised or depreciated over their useful economic
lives. Useful economic lives are based on estimates of the period that the assets will generate revenue, which
are periodically reviewed for continued appropriateness. Changes to estimates can result in significant
variations in the carrying value and amounts charged to the consolidated income statement in specific
periods.
(d) Provisions
The Group determines the provisions based on management’s assessment of relevant information and advice
available at the time of preparing the financial statements. Outcomes are uncertain and dependent on future
events. Where outcomes differ from management’s expectations, differences from the amount initially
provided are reflected in the consolidated income statement in the period the outcome it determined.
(e) Taxation
The Group calculates its current and deferred tax assets and liabilities based on management’s assessment of
relevant information and advice. Where outcomes differ from the amounts initially provided the difference
is reflected in the consolidated income statement in the period the outcome it determined.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
47
5. REVENUE
An analysis of the Group’s revenue is as follows:
Group
2016
$’000
2015
$’000
Execution and clearing commissions 269,661 285,184
Trading and broking 38,832 40,010
Desk facility and market data fees 11,004 12,012
Net interest income 3,499 2,951
Other income 7,374 7,590
330,370 347,747
Group
31 December 2016
North
America
$’000
Europe
$’000
Asia
$’000
Total
$’000
Commodities 39,865 172,017 23,004 234,886
Futures and Securities 7,406 15,460 - 22,866
Market Access - 69,358 - 69,358
Other 611 2,647 2 3,260
Revenue 47,882 259,482 23,006 330,370
Group
31 December 2015
North
America
$’000
Europe
$’000
Asia
$’000
Total
$’000
Commodities 37,536 179,670 18,627 235,833
Futures and Securities 5,715 24,612 - 30,327
Market Access - 80,035 - 80,035
Other 714 838 - 1,552
Revenue 43,965 285,155 18,627 347,747
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
48
6. OPERATING PROFIT
This has been arrived at after charging:
Group
Notes
2016
$’000
2015
$’000
Staff costs 8 159,970 167,069
Depreciation of property, plant and equipment 15 2,535 4,098
Amortisation of other intangible assets 14 389 606
Charges under operating leases 30 7,335 10,412
Provision for bad and doubtful debts 22(b) 126 46
Foreign exchange (gains) / losses (393) 510
7. AUDITOR’S REMUNERATION
Group
2016
$’000
2015
$’000
Audit of the Group’s annual accounts 157 172
Audit of the Company’s subsidiaries 695 723
Total audit fees 852 895
Fees payable to the Group’s auditor for other
services comprise:
Audit-related assurance services 122 74
Tax compliance services 9 -
Tax advisory services 28 -
Other assurance services - 2
Other services 37 -
Total non-audit fee 196 76
Audit fees for the Group for the year ended 31 December 2016 and the prior year were paid by a group
undertaking.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
49
8. STAFF COSTS
Group
2016
Number
2015
Number
Front Office 275 307
Control & Support 225 217
Average monthly number of staff 500 524
Group
2016
$’000
2015
$’000
Aggregate wages and salaries 141,689 148,224
Employer’s National Insurance Contributions and
similar taxes
14,524
14,878
Short-term monetary benefits 2,540 2,660
Defined pension contribution cost 1,217 1,307
Total staff costs 159,970 167,069
As at 31 December 2016, there were contributions totalling $171,119 (2015: $207,000) payable to the
defined contribution pension scheme by the Group.
9. OTHER INCOME AND EXPENSE
Group
2016
$’000
2015
$’000
Other income
Dividends received 24 50
Other 2 45
26 95
Group
Notes
2016
$’000
2015
$’000
Other expense
Leasehold dilapidations and provisions 27 876 (900)
Impairment of Goodwill 13 - (3,000)
876 (3,900)
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
50
10. FINANCE INCOME AND EXPENSE
Group
2016
$’000
2015
$’000
Finance income
Bank interest receivable 388 129
Interest receivable on held to maturity investments 1,448 425
1,836 554
Group
2016
$’000
2015
$’000
Finance expense
Bank interest payable (2,057) (1,856)
(2,057) (1,856)
Included in bank interest expenses, above, are credit facility expenses of $1,137,196 (2015: $1,774,000).
For further details on the credit facility, refer to note 23.
11. TAXATION
(a) Tax charge / (credit)
Group
Notes
2016
$’000
2015
$’000
Current tax
UK and foreign corporation tax on profit for the year 5,737 4,395
Adjustment in respect of prior years 143 15
5,880 4,410
Deferred tax
Origination and reversal of temporary differences 1,433 983
Adjustment in respect of prior years – US losses (582) (5,012)
Adjustment in respect of prior years – other (216) (406)
25 635 (4,435)
Tax charge / (credit) for the year 11(b) 6,515 (25)
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
51
11. TAXATION (CONTINUED)
(b) Reconciliation between tax charge / credit and profit before tax
The tax assessed for the year is higher (2015: lower) than the standard rate of corporation tax in the UK
20.00% (2015: 20.25%). The standard rate of corporation tax in the UK reduced from 21% to 20% from 1
April 2015. Accordingly, UK corporation tax for this accounting period has been calculated at 20.00% of
the estimated assessable profits for the period. Taxation for other jurisdictions is calculated at rates
prevailing in the relevant jurisdictions. Finance (No. 2) Act 2015 enacted reductions in the UK corporation
tax rate to 19% with effect from 1 April 2017 and 18% with effect from 1 April 2020. Finance Act 2016
enacted a further reduction in the UK corporation tax rate to 17% by 2020 and this reduction in the tax rate
will impact the current tax charge in future periods.
Group
Notes
2016
$’000
2015
$’000
Profit before tax 27,007 17,619
Expected tax expense based on the standard rate of
corporation tax in the UK of 20.00% (2015: 20.25%) 5,401 3,568
Explained by:
Effect of overseas tax rates 546 391
Expenses not deductible for tax purposes 745 1,422
Income not subject to tax (5) (11)
Tax losses not recognised for deferred tax purposes 315 62
Foreign exchange and other differences 168 (54)
Prior year adjustments (655) (5,403)
Tax charge / (credit) for the year 11(a) 6,515 (25)
(c) Amounts recognised in other comprehensive income
Amounts directly recognised in the consolidated statement of other comprehensive income relate to
available-for-sale financial assets. The amount recognised in 2016 is a deferred tax credit of $104,000
(2015: $379,000).
12. DIVIDENDS PAID AND PROPOSED
The Company declared and made a dividend payment of $20,000,000 during the year (2015: $nil).
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
52
13. GOODWILL
Group
$’000
Cost
At 1 January 2015, 1 January 2016
and 31 December 2016 150,101
Accumulated impairment losses
At 1 January 2015 6,132
Impairment charges (note 9) 3,000
At 31 December 2015 and 31 December 2016 9,132
Net book value
At 31 December 2015 and 31 December 2016 140,969
(a) Goodwill impairment testing
For the purpose of impairment testing, goodwill has been allocated to the cash generating units (‘CGUs’)
which represent the level at which goodwill is monitored and managed:
Group
Energy
$’000
Agri-
culturals
$’000
Protrader
$’000
Total
$’000
At 31 December 2015 and 2016 126,311 11,416 3,242 140,969
The Group performed the annual impairment test as at 31 December 2016 and 2015. In assessing whether
impairment is required, the carrying value of the CGU is compared with the recoverable amount which is
determined by fair value less cost of disposal.
(b) Key assumptions
▪ The fair value less cost of disposal is determined by applying an earnings multiple to the future cash
flows of each CGU arising in future periods.
▪ The Group prepares the cash flow forecasts derived from the most recent Board approved financial
budgets for the next three years. As the Group performance is continuously monitored against budget
and subject to Board supervision, the cash flow forecasts are considered to be Level 2.
▪ The earnings (‘EBITDA’) multiples applied are derived from comparable peer multiples.
▪ Comparable peers are those which our stakeholders evaluate our performance against whilst the
multiples are obtained from third party market data providers. Whilst third party data considers this to
be a Level 1 input, management applies a level of judgement in determining the EBITDA mulitiple and
as such is considered to be a Level 2 input.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
53
14. OTHER INTANGIBLE ASSETS
Group
Software
development
$’000
Trademarks
$’000
Total
$’000
Cost
At 1 January 2015 8,135 46 8,181
Additions 466 - 466
At 1 January 2016 8,601 46 8,647
Additions 155 - 155
Disposals (2,089) - (2,089)
At 31 December 2016 6,667 46 6,713
Impairment provisions and
amortisation
At 1 January 2015 7,270 - 7,270
Charge for the year (note 6) 606 - 606
At 1 January 2016 7,876 - 7,876
Charge for the year (note 6) 389 - 389
Disposals (2,089) - (2,089)
At 31 December 2016 6,176 - 6,176
Net book value
At 31 December 2016 491 46 537
At 31 December 2015 725 46 771
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
54
14. OTHER INTANGIBLE ASSETS (CONTINUED)
Company
Trademarks
$’000
Total
$’000
Cost
At 1 January 2015 and 1 January 2016 - -
Transferred in during the year 46 46
At 31 December 2016 46 46
Impairment provisions and
amortisation
At 1 January 2015, 1 January 2016
and 31 December 2016 - -
Net book value
At 31 December 2016 46 46
At 31 December 2015 - -
Trademarks of $45,534 were transferred to the Company from liquidation proceedings of EasyScreen
Limited during the year. EasyScreen Limited is a subsidiary held directly by the Company.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
55
15. PROPERTY, PLANT AND EQUIPMENT
Group
Leasehold
improve-
ments
$’000
Computer
expenses
$’000
Furniture,
fixtures and
fittings
$’000
Total
$’000
Cost
At 1 January 2015 8,858 20,443 4,544 33,845
Additions 181 603 47 831
Disposals (633) (3,089) (199) (3,921)
At 1 January 2016 8,406 17,957 4,392 30,755
Additions 333 918 6 1,257
Disposals (3,248) (2,525) (634) (6,407)
At 31 December 2016 5,491 16,350 3,764 25,605
Depreciation
At 1 January 2015 5,666 17,625 3,508 26,799
Charge for the year (note 6) 1,645 1,831 622 4,098
Disposals (633) (3,089) (199) (3,921)
At 1 January 2016 6,678 16,367 3,931 26,976
Charge for the year (note 6) 1,178 1,157 200 2,535
Disposals (3,248) (2,525) (634) (6,407)
At 31 December 2016 4,608 14,999 3,497 23,104
Net book value
At 31 December 2016 883 1,351 267 2,501
At 31 December 2015 1,728 1,590 461 3,779
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
56
16. INVESTMENTS
(a) Available-for-sale investments
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Cost
At 1 January 7,261 8,990 3,165 4,727
Revaluation (365) (1,729) (31) (1,562)
At 31 December 6,896 7,261 3,134 3,165
Listed investments 1,901 1,603 892 810
Unlisted investments 4,995 5,658 2,242 2,355
6,896 7,261 3,134 3,165
Investments comprise shares and seats held in clearing houses which are deemed relevant to the Group’s
trading activities and are classified as available-for-sale financial assets and recorded at fair value with
changes in fair value reported in equity. The fair value for these investments is determined as the latest
available traded price.
(b) Investments in subsidiaries
Company
2016
$’000
2015
$’000
Cost
At 1 January 331,722 362,563
Additions - 7,305
Impairment - (38,146)
At 31 December 331,722 331,722
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
57
16. INVESTMENTS (CONTINUED)
(c) Group subsidiaries and undertakings
The subsidiaries of the Company as at 31 December 2016 are as follows:
Subsidiaries held directly
Name / Registered office
Country of
incorporation
/ Principal
place of
business Class
Proportion of
ownership
interest Nature of business
4GP Leases Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Dormant
EasyScreen Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Dormant
Marex Financial Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Commodities and
financial
instruments
broker and clearer
Marex Hong Kong Limited
20/F Alexandra House, 16-
20 Chater Road, Central,
Hong Kong
Hong Kong Ordinary
shares
100% Futures and options
broking
Marex North America LLC
360 Madison Ave, Third
Floor, New York 10017
United States of
America
Membership
interest
100% Commodities and
financial
instruments
broker and clearer
Marex Spectron International
Limited 1
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Energy OTC
broking
Marex Services Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Dormant
Marex USA Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Dormant
Spectron Services Limited
155 Bishopsgate, London,
EC2M 3TQ
England and
Wales
Ordinary
shares
100% Facilities services
1 Marex Spectron International Limited operates branches in the following countries:
▪ Canada – Suite 400, 4th Floor, 110-9th Avenue SW, Calgary, Alberta, Canada
▪ Germany – Romerstrass 31 , 63486 Bruchkobel, Frankfurt
▪ Norway – Kronprinsesse Marthas Plass 1, 0160 Oslo, Norge
▪ United States of America – 360 Madison Ave, Third Floor, New York 10017
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
58
16. INVESTMENTS (CONTINUED)
(c) Group subsidiaries and undertakings (continued)
Subsidiaries held indirectly
Name / Registered office
Country of
incorporation
/ Principal
place of
business Class
Proportion
of
ownership
interest
Nature of
business
Carlton Commodities 2004 LLP
155 Bishopsgate, London, EC2M
3TQ
England and
Wales
Partnership
interest
N/A Commodity and
option trading
Marex Spectron Asia Pte Limited
8 Marina Way, 33-06 Asia Tower
1, Singapore, 018960
Singapore Ordinary
shares
100% Freight broking
Marex Spectron Inc.
360 Madison Ave, Third Floor,
New York 10017
United States of
America
Ordinary
shares
100% Dormant
Marex Spectron Ltd
20/F Alexandra House, 16-20
Chater Road, Central, Hong Kong
Hong Kong Ordinary
shares
100% Dormant
Marex Spectron Pte Ltd
8 Marina Way, 33-06 Asia Tower
1, Singapore, 018960
Singapore Ordinary
shares
100% Dormant
Marex Spectron Securities LLP
155 Bishopsgate, London, EC2M
3TQ
England and
Wales
Partnership
interest
N/A Dormant
Marex Trading Services (Gibraltar)
Limited
Steadfast Corporate Services
Limited, 19A town Range, P.O.
Box 872, Gibraltar
Gibraltar Ordinary
shares
100% Dormant
Nanolytics Capital Advisors
Limited
155 Bishopsgate, London, EC2M
3TQ
England and
Wales
Ordinary
shares
100% Appointed
representative
of a fund
management
company
Spectron Energy Asia Pte Limited
8 Marina Way, 33-06 Asia Tower
1, Singapore, 018960
Singapore Ordinary
shares
100% Energy OTC
broking
Spectron Energy Inc.
360 Madison Ave, Third Floor,
New York 10017
United States of
America
Ordinary
shares
100% Energy OTC
broking
Xeram SA
Walder Wyss Avocats, Rue
d’Italie 10, 1204 Genève
Switzerland Ordinary
shares
100% Dormant
All subsidiaries have a financial year end of 31 December with the exception of Carlton Commodities 2004
LLP and Marex Spectron Securities LLP which have a year end of 31 March.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
59
16. INVESTMENTS (CONTINUED)
(c) Group subsidiaries and undertakings (continued)
Other Related Entities
Name
Country of
incorporation Class
Proportion
of
ownership
interest
Nature of
business
Elian Employee Benefit Trustee
Limited, 44 Esplanade St Helier
Jersey, JE4 9WG
Channel Islands Ordinary
shares
Nil Trustee of the
employee
benefit trust
17. INVENTORY
The Group holds physical metal, in the form of London Metal Exchange warrants, measured at fair value.
These are generally held on a short-term basis.
18. OTHER ASSETS – NON-CURRENT
Non-current other assets relate to deferred proceeds from the sale of Eclipse Energy Holdings SA, which is
to be released from escrow on or before 3 January 2017.
As at 31 December 2016 these proceeds are due within one year and have been recognised as a current asset
under trade and other receivables.
19. SUBORDINATED LOANS DUE TO GROUP UNDERTAKINGS
The Revolving Subordinated Loan Agreement with Marex North America LLC was renewed during the year
with the approval of the CME. The new facility has a drawing termination date of 30 September 2018,
maturity date of 30 September 2021 and total credit line of $55,000,000 (2015: $45,000,000). The
subordinated borrowings of $17,500,000 (2015: $9,000,000) are unsecured and carry interest at the daily
three-month LIBOR plus 2.75% (2015: US Prime rate plus 2.75%).
The subordinated borrowings qualify as equity capital as defined by the CFTC regulation1.17d.
20. FINANCIAL INSTRUMENTS – FAIR VALUE THROUGH PROFIT AND LOSS (NON-CURRENT)
Financial instruments at fair value through profit or loss comprise US Treasuries that were provided as a
security deposit for a leasehold property and mature on 31 July 2018.
21. FINANCIAL INSTRUMENTS – HELD TO MATURITY
Held to maturity financial instruments comprises US Treasuries with maturity dates from January 2017 to
March 2018.
During the year the Group has pledged US Treasuries to counterparties as collateral for financing
transactions. Financial instruments which have been pledged in this way are held under certain terms and
conditions set out in specific agreements with each counterparty. In these agreements it is generally stated
that whilst the US Treasury is pledged at the counterparty the Group cannot:
▪ sell or transfer the financial instrument;
▪ dispose of the financial instrument; or
▪ have any third party rights associated with the financial instrument whereby it can be used as security
towards any further financing activities.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
60
22. TRADE AND OTHER RECEIVABLES
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Amounts due from exchanges, clearing
houses and other counterparties 558,848 572,156 - -
Trade debtors 21,107 19,798 - -
Default funds and deposits 42,959 42,991 - -
Amounts due from group undertakings - - 57 27,015
Loans receivable 645 849 - -
Other tax and social security taxes 1,635 2,987 - -
Other debtors 14,710 3,237 - -
Prepayments 6,397 6,381 - -
646,301 648,399 57 27,015
Included in the amounts due from exchanges, clearing houses and other counterparties are segregated
balances of $458,156,000 and non-segregated balances of $100,692,000.
Trade receivables disclosed above are classified as loans and receivables and, therefore, measured at
amortised cost with the exception of amounts due from exchanges, clearing houses and other counterparties
of $166,622,729 (2015: $279,906,000) which are classified as fair value through profit or loss.
Included in other debtors is $7,088,313 (2015: $827,000) which is due in more than one year, relating to
sign-on bonuses which are awarded to employees and amortised over the term of the contract.
Amounts due from exchanges, clearing houses and other counterparties and trade debtors are stated after
deducting impairment provisions of $1,299,000 (2015: $4,949,000).
(a) Ageing of past due, but not impaired, receivables
Group
2016
$’000
2015
$’000
Less than 30 days 5,272 4,455
31 to 60 days 1,846 1,793
61 to 90 days 701 1,161
91 to 120 days 449 394
More than 120 days 1,452 1,863
9,720 9,666
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
61
22. TRADE AND OTHER RECEIVABLES (CONTINUED)
(b) Reconciliation of the movement in provisions for bad and doubtful debts
Group
Notes
2016
$’000
2015
$’000
As at 1 January 4,949 4,889
Charged to the consolidated income
statement 6 126 46
Bad debts written off (3,778) -
Foreign exchange revaluation 2 14
At 31 December 1,299 4,949
The directors consider that the carrying amount of trade and other receivables is approximately equal to their
fair value.
23. SHORT-TERM BORROWINGS
Group
2016
$’000
2015
$’000
Unsecured borrowing at amortised cost
Bank overdraft 5,000 -
Revolving credit facility 35,000 -
40,000 -
The Group has an annually committed credit agreement with a current revolving loan facility of up to
$65,000,000 with a renewal date of 5 June 2017. As at 31 December 2016, $35,000,000 of the facility has
been utilised.
The credit agreement contains certain financial and other covenants. The Group was in compliance with all
applicable covenants throughout the year. Interest on the amount utilised is charged at LIBOR + 250 basis
points and on the unutilised portion at 100 basis points.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
62
24. DERIVATIVE INSTRUMENTS
Derivative assets and derivative liabilities at fair value through profit or loss comprise of over-the-counter
foreign exchange and precious metal contracts. These are entered to hedge over-the-counter foreign
exchange and precious metal contracts transacted between the Group and their customers.
Group
2016
$’000
2015
$’000
Financial assets carried at fair value through profit
or loss (‘FVTPL’)
Held for trading derivatives that are not designated in
hedge accounting relationships:
Forward foreign currency contracts 2,167 1,114
Foreign currency options 58 -
Precious metal forward contracts 21,787 3,822
Precious metal option contracts - -
24,012 4,936
Group
2016
$’000
2015
$’000
Financial liabilities carried at fair value through
profit or loss (‘FVTPL’)
Held for trading derivatives that are not designated in
hedge accounting relationships:
Forward foreign currency contracts 5,104 2,262
Foreign currency options 44 -
Precious metal forward contracts 6,787 1,280
Precious metal option contracts 92 -
12,027 3,542
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
63
25. DEFERRED TAX
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Revaluation of investments – available-
for-sale (411) (515) 120 111
Depreciation in excess of capital
allowances 1,815 1,856 - -
Tax losses 3,299 3,875 - -
Other 56 74 - -
31 December 4,759 5,290 120 111
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
At 1 January 5,290 477 111 (201)
(Charged) / credited to the income
statement (note 11(a)) (635) 4,435 - -
Credited to other comprehensive income 104 379 10 312
Foreign exchange differences and other - (1) (1) -
31 December 4,759 5,290 120 111
Deferred tax assets and liabilities are offset where the Group has a legally enforceable right to do so.
The reduction in the main rate of UK corporation tax to 20% from 1 April 2015 was substantively enacted on
2 July 2013. Deferred tax balances have been calculated at the effective tax rate ruling at the balance sheet
date. Finance (No. 2) Act 2015 enacted reductions in the UK corporation tax rate to 19% with effect from 1
April 2017 and 18% with effect from 1 April 2020. Finance Act 2016 enacted a further reduction in the UK
corporation tax rate to 17% by 2020.
The reduction of the UK corporation tax rate to 19% has been recognised in the deferred tax charge and
closing deferred tax position. However, the subsequent reduction to 17% from April 2020 has not been
recognised in the deferred tax charge and closing deferred tax position as its impact is not material.
(a) Unrecognised deferred tax assets
The Group has unrecognised deferred tax assets in respect of:
▪ employee compensation deductions of $4,445,000 (2015: $5,306,000). The potential deferred tax asset
at 17% (2015: 20%) is $756,000 (2015: $1,061,000). These assets have not been recognised as it is not
foreseeable when a tax deduction will arise; and
▪ tax losses of $11,240,000 (2015: $11,013,000). Of this amount, $11,240,000 (2015: $11,013,000)
relates to losses with no expiry date. Losses of $1,010,000 (2015: $246,000) are subject to approval by
the relevant tax authorities. These assets are not recognised on the basis of insufficient evidence
concerning profits being available against which deferred tax assets could be utilised.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
64
26. TRADE AND OTHER PAYABLES
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Amounts due to exchanges, clearing
houses and other counterparties 647,327 632,770 - -
Amounts due to group undertakings - - 1,620 -
Other tax and social security taxes 1,480 1,852 - -
Other creditors 1,400 8,191 - 643
Accruals and deferred income 57,373 63,937 257 196
707,580 706,750 1,877 839
Included in the amounts due to exchanges, clearing houses and other counterparties are segregated balances
of $458,117,000 and non-segregated balances of $189,210,000. Included in the non-segregated balance of
$189,210,000 is $42,556,078 which is classified as fair value through profit or loss.
The directors consider that the carrying amount of trade and other payables is approximately equal to their
fair value.
27. PROVISIONS
Group
Onerous
lease
$’000
Leasehold
dilapida-
tions
$’000
Total
$’000
Non-current
At 1 January 2016 196 1,217 1,413
Movement in the year:
Credited during the year (note 9) (4) (876) (880)
Utilised during the year (192) (24) (216)
Foreign exchange valuation - (52) (52)
(196) (952) (1,148)
At 31 December 2016 - 265 265
Onerous lease provisions relate to the excess of rent payable over rents receivable on sublet office space.
Inherent uncertainties in measuring the provision relate to estimates of the amount of rent that will be
received in the future on vacant property and estimating future rents on property where the current sublease
is of a shorter duration than the head lease. The provision was utilised during the year with no further
uncertainties to recognise in the current period.
Leasehold dilapidations relate to the estimated cost of returning a leasehold property to its original state at
the end of the lease in accordance with the lease terms. The main uncertainty relates to estimating the cost
that will be incurred at the end of the lease. The provision was released during the year upon renegotiation
of the lease agreement. The new lease agreement terminates 22 March 2027.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
65
28. SHARE CAPITAL
Group and Company
Issued and fully paid Issued and fully paid
2016
Number
2016
$’000
2015
Number
2015
$’000
Ordinary shares of $0.000165 each 106,491,588 18 106,491,588 18
Non-voting ordinary shares of
$0.000165 each
3,986,376
1
3,986,376
1
Deferred shares of $1.65 each 106,798,427 176,217 106,798,427 176,217
Growth shares of $0.000165 each 13,981,025 2 14,164,766 2
231,257,416 176,238 231,441,157 176,238
Group and Company
Ordinary
shares
Number
Non-voting
ordinary
shares
Number
Deferred
shares
Number
Growth
shares
Number
Total
Number
At 1 January 2016 106,491,588 3,986,376 106,798,427 14,164,766 231,441,157
Shares cancelled during
the year - - - (183,741) (183,741)
At 31 December 2016 106,491,588 3,986,376 106,798,427 13,981,025 231,257,416
Growth shares of $183,741 were cancelled during the year following the resignation of a director of the
Group.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
66
28. SHARE CAPITAL (CONTINUED)
The rights of the shares are as follows:
Class of share Rights
Ordinary shares Full voting rights and right to participate in ordinary dividends ranking
pari passu with non-voting ordinary shares. In the event of a winding
up, entitled to a return of capital ranking pari passu with non-voting
ordinary shares and no right of redemption.
Non-voting ordinary shares As per ordinary shares, other than having no voting rights.
Deferred shares No voting rights, no right to participate in dividends and no right to
redemption. In the event of a winding up, entitled to a return of capital
ranking pari passu with ordinary shares for any capital in excess of £50
billion.
Growth shares No voting rights, no rights to participate in dividends, no entitlement to
participate in winding up and no right of redemption.
In 2010, 2012 and 2015 the Group issued growth shares to 18 individuals,
which entitle the holders to a share of the proceeds from a ‘liquidity
event’, such as an Initial Public Offering or a sale, if the proceeds
exceeded some specific level thereby diluting existing ordinary
shareholders. The holders of growth awards are not entitled to receive
dividends nor do they have voting rights and cannot impact the timing of
a transaction.
The growth shares vest over 3 to 5 years, but do not expire. The growth
awards can be settled through the issuance of ordinary shares, whereby
the Company issues the growth award holder a number of ordinary
shares equal in value to the growth award amount, or in cash.
The directors’ view is that it is currently probable the growth awards will
be settled in shares and, therefore, they are treated as equity-settled share
based payments.
29. RESERVES
The following describes the nature and purpose of each reserve within total equity:
Reserves Description
Share capital Amount subscribed for share capital at nominal value.
Share premium Amount of consideration received over and above the par value of shares.
Retained earnings Cumulative net gains and losses recognised in the income statement or
statement of other comprehensive income.
Revaluation reserve Cumulative unrealised gains on investments in exchanges that are held as
available-for-sale and recognised in equity.
Other reserves Foreign currency translation reserve.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
67
30. LEASE COMMITMENTS
The Group has entered into commercial leases on its properties.
The lessee has the options of renewal on each of these leases subject to negotiation between the Group, as
lessee, and each landlord in the period preceding the expiration of each lease. There were no restrictions
placed upon the lessee by entering into these leases.
Group
Notes
2016
$’000
2015
$’000
Lease payments under operating leases
recognised as an expense in the year 6 7,335 10,412
The total future minimum lease payments are due as follows:
Group
2016
$’000
2015
$’000
Within one year 6,393 8,190
In the second to fifth years inclusive 13,794 9,726
After five years 470 -
20,657 17,916
The total sublease receipts included in the income statement during the year is $1,949,074 (2015: $331,844).
The total future minimum sublease receipts are due as follows:
Group
2016
$’000
2015
$’000
Within one year 412 332
In the second to fifth years inclusive 1,537 -
1,949 332
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
68
31. FINANCIAL INSTRUMENTS
(a) Capital risk management
For the purpose of the Group’s capital management, capital includes issued share capital, share premium and
all other equity reserves attributable to the equity holders of the parent as disclosed in notes 28 and 29. The
primary objective of the Group’s capital management is to maximise the shareholder value.
In order to achieve this overall objective, the Group’s capital management, amongst other things, aims to
ensure that it meets financial covenants attached to the interest-bearing loans and borrowings that define
capital structure requirements. Breaches in meeting the financial covenant would permit the bank to
immediately call loans and borrowings. There have been no breaches in the financial covenants of any
interest-bearing loans and borrowing in the current year.
Many of the Group’s material operating subsidiaries are subject to regulatory restrictions and minimum
capital requirements. At 31 December 2016, each of these subsidiaries had net capital in excess of the
requisite minimum requirements.
No changes were made in objectives, policies or processes for managing capital during the year.
(b) Categories of financial instruments
Some of the Group’s assets are carried at fair value or contract amounts that approximate fair value.
Set out, below, is an analysis of the categories of financial instruments. Due to the nature of the underlying
assets, the carrying value approximates fair value.
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Financial assets:
Cash and cash equivalents 188,178 158,261 486 116
188,178 158,261 486 116
At fair value through the income
statement:
Inventory - 15,870 - -
Amounts due from exchanges, clearing
houses and other counterparties 166,623 279,906 - -
Financial instruments – fair value through
profit or loss 653 658 - -
Derivative instruments 24,012 4,936 - -
191,288 301,370 - -
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
69
31. FINANCIAL INSTRUMENTS (CONTINUED)
(b) Categories of financial instruments (continued)
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Available-for-sale at fair value through
other comprehensive income:
Investments 6,896 7,261 3,134 3,165
6,896 7,261 3,134 3,165
Held-to-maturity investments:
Financial instruments – held to maturity 120,209 119,524 - -
120,209 119,524 - -
Loans and receivables
Amounts due from exchanges, clearing
houses and other counterparties 392,225 292,250 - -
Other assets - 908 - -
Trade debtors 21,107 19,798 - -
Default funds and deposits 42,959 42,991 - -
Amounts due from group undertakings - - 57 27,015
Loans receivable 645 849 - -
Other tax and social security taxes 1,635 2,987 - -
Other debtors 3,523 3,237 - -
Subordinated loans due to group
undertakings - - 17,500 9,000
462,094 363,020 17,557 36,015
968,665 949,436 21,177 39,296
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
70
31. FINANCIAL INSTRUMENTS (CONTINUED)
(b) Categories of financial instruments (continued)
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Financial liabilities
At fair value through the income
statement:
Amounts due to exchanges, clearing
houses and other counterparties 42,556 - - -
Derivative instruments 12,027 3,542 - -
54,583 3,542 - -
At amortised cost:
Amounts due to exchanges, clearing
houses and other counterparties 604,771 632,770 - -
Amounts due to group undertakings - - 1,620 -
Other tax and social security taxes 1,480 1,852 - -
Other creditors 1,400 8,191 - 643
Accruals and deferred income 57,373 63,937 257 196
Repurchase agreements - 18,938 - -
Short-term borrowings 40,000 - - -
Provisions 265 1,413 - -
705,289 727,101 1,877 839
759,872 730,643 1,877 839
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
71
31. FINANCIAL INSTRUMENTS (CONTINUED)
(c) Financial instruments subject to offsetting, enforceable master netting arrangements and similar
agreements
As a member of the LME, the Group is subject to the settlement and margining rules of LME Clear. The
majority of products transacted by the Group are LME forward contracts. LME forwards that are in-the-
money do not settle in cash until maturity (‘prompt’) date, while the firm is required to post margin to cover
loss-making contracts daily. In accordance with the LME Clear rules, the Group is able to utilise forward
profits to satisfy daily margin requirements and are set-off against loss-making contracts. Consequently,
amounts due from exchanges, clearing houses and other counterparties are presented on a net basis in the
balance sheet.
The effect of offsetting is disclosed, below:
Group
31 December 2016
Gross
amount
$’000
Amounts
set-off
$’000
Net
amount
presented
$’000
Non-cash
collateral
rec’d /
(pledged)
$’000
Cash
collateral
rec’d /
(pledged)
$’000
Net
amount
$’000
Financial assets
Amounts due from
exchanges, clearing houses
and other counterparties 1,489,641 (930,793) 558,848 - - 558,848
Financial liabilities
Amounts due to exchanges,
clearing houses and other
counterparties 1,578,120 (930,793) 647,327 (84,145) - 563,182
Group
31 December 2015
Gross
amount
$’000
Amounts
set-off
$’000
Net
amount
presented
$’000
Non-cash
collateral
rec’d /
(pledged)
$’000
Cash
collateral
rec’d /
(pledged)
$’000
Net
amount
$’000
Financial assets
Amounts due from
exchanges, clearing houses
and other counterparties 1,091,640 (519,484) 572,156 - - 572,156
Financial liabilities
Amounts due to exchanges,
clearing houses and other
counterparties 1,152,254 (519,484) 632,770 (68,589) - 564,181
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
72
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives
The Group’s activities expose it to a number of financial risks including market risk, operational risk, credit
risk and liquidity risk as discussed in the strategic report.
The Group manages these risks through various control mechanisms and its approach to risk management is
both prudent and evolving.
Overall responsibility for risk management rests with the Board. Dedicated resources within the Risk
Department control and manage the exposures of the Group’s own positions, the positions of its clients and
its exposures to its counterparties as well as operational exposures, within the risk appetite set by the Board.
Credit risk
The maximum credit risk exposure relating to financial assets is represented by the carrying value as at the
balance sheet date. Credit risk in the Group principally arises from cash and cash equivalents deposited with
third party institutions, exposures from transactions and balances with exchanges and clearing houses, and
exposures resulting from transactions and balances relating to customers and counterparties, some of which
have been granted credit lines.
The Group only makes treasury deposits with banks and financial institutions that have received approval
from the Group’s Executive Credit Risk Committee. These deposits are also subject to counterparty limits
with respect to concentration and maturity.
The Group’s exposure to customer and counterparty transactions and balances is managed through the
Group’s credit policies and, where appropriate, the use of initial and variation margin credit limits in
conjunction with overall position limits for all customers and counterparties. These exposures are monitored
both intraday and overnight. The limits are set by the Group’s Credit Risk Committee through a formalised
process.
The maximum credit risk exposure relating to financial assets is represented by the carrying value as at the
balance sheet date.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
73
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Credit quality
The table below does not take into account collateral held.
Group Company
2016
$’000
2015
$’000
2016
$’000
2015
$’000
AA and above 65,437 85,962 - -
AA- 290,814 233,780 486 116
A+ 34,349 42,471 - -
A 193,223 177,825 - -
A- 9,767 2,772 - -
BBB+ 1,301 3,438 - -
Lower and unrated 373,774 403,188 20,691 39,180
968,665 949,436 21,177 39,296
Group Company
Financial assets
2016
$’000
2015
$’000
2016
$’000
2015
$’000
Investments – available-for-sale 6,896 7,261 3,134 3,165
Other assets - 908 - -
Financial instruments – held to maturity 120,209 119,524 - -
Financial instruments – fair value through
profit or loss 653 658 - -
Inventory - 15,870 - -
Derivative assets 24,012 4,936 - -
Amounts due from exchanges, clearing
houses and other counterparties 558,848 572,156 - -
Trade debtors 21,107 19,798 - -
Default funds and deposits 42,959 42,991 - -
Amounts due from group undertakings - - 57 27,015
Loans receivable 645 849 - -
Other debtors 3,523 3,237 - -
Cash and cash equivalents 188,178 158,261 486 116
Other tax and social security taxes 1,635 2,987 - -
Subordinated loans due to group
undertakings - - 17,500 9,000
968,665 949,436 21,177 39,296
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
74
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Credit quality (continued)
The Group has received collateral of $8,636,349 (2015: $nil) in respect of its derivative assets. The
collateral has been recognised in the amounts due to exchanges, clearing houses and other counterparties as
at 31 December 2016.
Market risk
The Group’s activities expose it to financial risks primarily generated through foreign exchange, interest rate
and commodity market price exposures which are outlined in the strategic report.
Market risk sensitivity
As principally an intermediary, the Group’s market risk exposure is modest. It manages this market risk
exposure using appropriate risk management techniques within pre-defined and independently monitored
parameters and limits.
The Group uses a range of tools to monitor and limit market risk exposures. These include Value-at-Risk
(‘VaR’), sensitivity analysis and stress testing.
Value at risk (‘VaR’)
VaR is a technique that estimates the potential losses that could occur on risk positions as a result of
movements in market rates and prices over a specified time horizon and to a given level of confidence.
The VaR model used by the Group is based upon the Monte Carlo simulation technique. This model derives
plausible future scenarios from past series of recorded market rates and prices, taking account of inter-
relationships between different markets and rates, including interest rates and foreign exchange rates. The
model also incorporates the effect of option features on the underlying exposures.
The Monte Carlo simulation model used by the Group incorporates the following features:
▪ 5,000 simulations using a variance covariance matrix;
▪ simulations generated using geometric Brownian motion;
▪ an exceptional decay factor is applied across an estimation period of 250 days; and
▪ VaR is calculated to a 1-day, 99.75% one tail confidence level.
The Group validates VaR by comparing to alternative risk measures, for example, scenario analysis and
exchange initial margins as well as the back testing of calculated results against actual profit and loss.
Although a valuable guide to risk, VaR should always be viewed in the context of its limitations, for
example:
▪ the use of historical data as a proxy for estimating future events may not encompass all potential
events, particularly those which are extreme in nature;
▪ the use of a 1-day holding period assumes that all positions can be liquidated or hedged in 1-day. This
may not fully reflect the market risk arising at times of severe liquidity stress, when a 1-day holding
period may be insufficient to liquidate or hedge all positions fully;
▪ the use of a 99.75% confidence level, by definition, does not take into account losses that might occur
beyond this level of confidence;
▪ the VaR, disclosed below, is calculated on the basis of exposures outstanding at the close of business
and, therefore, does not necessarily reflect intra-day exposure; and
▪ VaR is unlikely to reflect loss potential on exposures that only arise under significant market moves.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
75
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Value at risk (‘VaR’)
The Group recognises these limitations by augmenting its VaR limits with other position and sensitivity limit
structures. The Group also applies a wide range of stress testing, both on individual portfolios and on the
Group’s consolidated positions. The VaR as at 31 December 2016 was $1,135,273 (2015: $662,000) and the
average monthly VaR for the year ended 31 December 2016 was $1,183,237 (2015: $1,091,000).
Foreign currency risk
As the majority of the revenue generated, and asset and liabilities of the Group are in US Dollars, there is
minimal exposure to structural currency risk. Management monitors currency exposure on a daily basis and
buys or sells currency to minimise the exposure.
Foreign exchange sensitivity
The majority of the Group’s net assets are in US Dollars which minimises the effect exchange rate
fluctuations will have on overall net assets.
Interest rate risk
The Group is exposed to interest rate risk on cash, investments, derivatives, client balances and bank
borrowings.
The main interest rate risk is derived from interest-bearing deposits in which the Group invests surplus funds
and bank borrowings.
The Group’s exposure to interest rate fluctuations is limited through the offset that exists between the bulk of
its interest bearing assets and interest bearing liabilities. Since the return paid on client liabilities is generally
reset to prevailing market interest rates on an overnight basis, the Group is only exposed for the time it takes
to reset its investments which are held at rates fixed for a maturity which does not exceed three months, with
the exception of US Treasuries which have a maturity of up to two years.
Operational risk
Operational risk is the risk of loss arising through failures associated with personnel, processes or systems, or
from external events. It is inherent in every business organisation and covers a wide spectrum of issues.
Operational risk is managed through systems and procedures in which processes are documented,
authorisation is independent, and transactions are monitored and reconciled.
The Group maintains disaster recovery or contingency facilities to support operations and ensure business
continuity. The invocation of these facilities is regularly tested.
Compliance or Regulatory risk arises from a failure or inability to comply with the laws, regulations or codes
applicable specifically to the Group. Non-compliance can lead to fines, public reprimands, enforced
suspensions of services, or in extreme cases, withdrawal of authorisation to operate.
Companies within the Group are subject to authorisation by the LME, the CME Group of exchanges, NLX,
DGCX, London Stock Exchange, ICE US, NYSE Liffe, ICE Futures and Eurex. The Group is regulated in
the UK by the FCA (which regulates the Group under consolidated supervision), in the US by the NFA and
CFTC, in Hong Kong by the SFC, and in Singapore by the MAS and IES.
Geographical risk arises from the physical separation of some elements of the Group from the central control
locations. Internal control failure is the risk arising from the inadequacy or breakdown of critical internal
control processes.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
76
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Concentration risk
In order to avoid excessive concentrations of risk with respect to bank counterparties, the Group maintains a
diversified portfolio of cash accounts in accordance with the Board’s risk appetite.
To mitigate the concentration of credit risk exposure to a particular single customer, counterparty or group of
affiliated customers or counterparties, the Group monitors these exposures carefully and ensures that these
remain within pre-defined limits. Large exposure limits are determined in accordance with appropriate
regulatory rules.
Further concentration risk controls are in place to limit exposure to clients or counterparties within single
countries of origin and operation through specific country credit risk limits as set by the Board Risk
Committee.
The largest concentration of cash balances as at 31 December 2016 was 74% (2015: 82%) to a UK-based,
AA- rated global banking group (2015: UK-based, AA- rated global banking group).
The largest concentration of exposures to exchanges, clearing houses and other counterparties as at 31
December 2016 was 30% (2015: 49%) to a non-rated global clearing house (2015: non-rated global clearing
house).
Liquidity risk
The Group defines liquidity risk as the failure to meet its day-to-day capital and cash flow requirements.
Liquidity risk is assessed and managed under the Individual Liquidity Adequacy Assessment (‘ILAA’) and
Liquidity Risk Framework. To mitigate liquidity risk, the Group has implemented robust cash management
policies and procedures that monitor liquidity daily to ensure that the Group has sufficient resources to meet
its margin requirement at clearing houses and third party brokers. In the event of a liquidity issue arising, the
Group has recourse to existing global cash resources after which it could draw down on a $30 million
committed revolving credit facility as an additional contingency funding.
There are strict guidelines followed in relation to products and duration into which excess liquidity can be
invested. Excess liquidity is invested in highly liquid instruments, such as cash deposits with financial
institutions for a period of less than three months and US Treasuries with a maturity of up to two years.
The financial liabilities are based upon rates set on a daily basis, apart from the financing of the warrant
positions and the credit facility where the rates are set for the term of the loan. For assets not marked-to-
market there is no material difference between the carrying value and fair value.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
77
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Liquidity risk (continued)
Liquidity risk exposures
The following table details the Group’s expected undiscounted contractual maturity for non-derivative
financial liabilities:
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due to
exchanges, clearing
houses and other
counterparties 647,327 - - - 647,327
Other tax and social
security taxes - 1,480 - - 1,480
Other creditors - 1,400 - - 1,400
Accruals and deferred
income - 52,438 4,601 334 57,373
Short-term borrowings - 40,000 - - 40,000
At 31 December 2016 647,327 95,318 4,601 334 747,580
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due to
exchanges, clearing
houses and other
counterparties 632,770 - - - 632,770
Other tax and social
security taxes - 1,852 - - 1,852
Other creditors - 8,191 - - 8,191
Accruals and deferred
income - 59,831 4,106 - 63,937
Repurchase agreements - 18,938 - - 18,938
At 31 December 2015 632,770 88,812 4,106 - 725,688
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
78
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Liquidity risk (continued)
Company
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due to group
undertakings 1,620 - - - 1,620
Accruals and deferred
income - 257 - - 257
At 31 December 2016 1,620 257 - - 1,877
Company
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Other creditors - 643 - - 643
Accruals and deferred
income - 196 - - 196
At 31 December 2015 - 839 - - 839
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
79
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Liquidity risk (continued)
Shown below is the Group’s expected undiscounted contractual maturity for non-derivative financial assets:
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due from
exchanges, clearing
houses and other
counterparties 558,848 - - - 558,848
Trade debtors - 21,107 - - 21,107
Default funds and
deposits - 42,959 - - 42,959
Loans receivable 436 11 198 - 645
Other debtors - 3,281 18 224 3,523
Cash and cash equivalents 188,178 - - - 188,178
Other tax and social
security taxes - 1,635 - - 1,635
At 31 December 2016 747,462 68,993 216 224 816,895
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due from
exchanges, clearing
houses and other
counterparties 572,156 - - - 572,156
Other assets - - - 908 908
Trade debtors 19,798 - - - 19,798
Default funds and
deposits - 42,991 - - 42,991
Loans receivable 544 13 292 - 849
Other debtors - 328 198 11 537
Cash and cash equivalents 158,261 - - - 158,261
Inventory - 15,870 - - 15,870
Other tax and social
security taxes - 2,987 - - 2,987
At 31 December 2015 750,759 62,189 490 919 814,357
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
80
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Liquidity risk (continued)
Company
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due from group
undertakings 57 - - - 57
Cash and cash equivalents 486 - - - 486
Subordinated loans due to
group undertakings - - - 17,500 17,500
At 31 December 2016 543 - - 17,500 18,043
Company
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Amounts due from group
undertakings 27,015 - - - 27,015
Cash and cash equivalents 116 - - - 116
Subordinated loans due to
group undertakings - - - 9,000 9,000
At 31 December 2015 27,131 - - 9,000 36,131
Both assets and liabilities are included to understand the Group’s liquidity risk management as the liquidity
is managed on a net asset and liability basis.
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
81
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Liquidity risk (continued)
The following table details the Group’s expected contractual maturity for derivative financial assets and
derivative financial liabilities:
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Derivative instruments -
assets - 23,216 442 354 24,012
Derivative instruments -
liabilities - (11,901) (120) (6) (12,027)
At 31 December 2016 - 11,315 322 348 11,985
Group
On demand
$’000
Less than 3
months
$’000
3 to 12
months
$’000
1 to 5
years
$’000
Total
$’000
Derivative instruments -
assets - 4,711 225 - 4,936
Derivative instruments -
liabilities - (2,982) (327) (233) (3,542)
At 31 December 2015 - 1,729 (102) (233) 1,394
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
82
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Fair value measurement
The information set out below provides information about how the Group determines fair values of various
financial assets and financial liabilities.
The following table provides an analysis of financial instruments that are measured subsequent to initial
recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable:
▪ Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets
for identical assets or liabilities;
▪ Level 2 fair value measurements are those derived from inputs other than quoted prices included within
Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e.
derived from prices); and
▪ Level 3 fair value measurements are those derived from valuation techniques that include inputs for the
asset or liability that are not based on observable market data (unobservable inputs).
The level 2 pricing for investments is based on the latest traded price. The level 2 pricing for derivative
instruments is based on counterparty information which provides daily valuations.
The following table shows an analysis of the financial assets and liabilities recorded at fair value shown in
accordance with the fair value hierarchy.
Group
Level 1
$’000
Level 2
$’000
Level 3
$’000
Total
$’000
Financial assets at FVTPL:
Amounts due from exchanges, clearing
houses and other counterparties 166,623 - - 166,623
Financial instruments – fair value through
profit or loss 653 - - 653
Derivative instruments - 24,012 - 24,012
Available-for-sale financial assets
Investments 1,901 4,995 - 6,896
Financial liabilities at FVTPL:
Amounts due to exchanges, clearing
houses and other counterparties (42,556) - - (42,556)
Derivative instruments - (12,027) - (12,027)
At 31 December 2016 126,621 16,980 - 143,601
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
83
31. FINANCIAL INSTRUMENTS (CONTINUED)
(d) Financial risk management objectives (continued)
Fair value measurement (continued)
Group
Level 1
$’000
Level 2
$’000
Level 3
$’000
Total
$’000
Financial assets at FVTPL:
Inventory 15,870 - - 15,870
Amounts due from exchanges, clearing
houses and other counterparties 279,906 - - 279,906
Financial instruments – fair value through
profit or loss 658 - - 658
Derivative instruments - 4,936 - 4,936
Available-for-sale financial assets
Investments 1,603 5,658 - 7,261
Financial liabilities at FVTPL:
Derivative instruments - (3,542) - (3,542)
At 31 December 2015 298,037 7,052 - 305,089
32. CLIENT MONEY
As required by the UK FCA’s Client Assets Sourcebook rules and the CFTC’s client money rules, the Group
maintains certain balances on behalf of clients with banks, exchanges, clearing houses and brokers in
segregated accounts. These amounts and the related liabilities to clients, whose recourse is limited to
segregated accounts, are not included in the statement of financial position as the Group is not beneficially
entitled thereto.
Group
2016
$’000
2015
$’000
Segregated assets at banks
(not recognised) 447,326 396,325
Segregated assets at exchanges, clearing
houses and other counterparties
(recognised) 465,318 466,800
912,644 863,125
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
84
33. COMPANY PROFIT AND LOSS
As permitted by section 408 of the Companies Act 2006, the Company has elected not to present its income
statement for the year. The Company reported a profit for year ended 31 December 2016 of $992,938 (2015:
$48,495,000).
34. EVENTS AFTER THE BALANCE SHEET DATE
The Group announced a $10 million receivables finance facility with RBS, effective from 13 February 2017.
There are no other significant events subsequent to the reporting date.
35. RELATED PARTY TRANSACTIONS
(a) Parent and ultimate controlling party
In these financial statements of the Group, being the Company and its subsidiaries, subsidiaries refer to the
entities controlled by the Company as disclosed in note 16(c).
In the directors’ opinion, the immediate parent and ultimate controlling party of the Company is Amphitryon
Limited, a company incorporated in Jersey, Channel Islands.
(b) Key Management Personnel
The remuneration paid to directors for their services to the Group was as follows:
Group
2016
$’000
2015
$’000
Aggregate wages and salaries 7,158 4,367
Short-term monetary benefits 71 27
7,229 4,394
The remuneration of the highest paid director for their services to the Group was $2,224,764 (2015:
$1,910,000). No pension contributions were made on their behalf whilst they were a director of the Group
(2015: $nil). No payments were made to directors in respect of loss of office (2015: $1,046,000). A loan of
$19,778 was forgiven during the year following the resignation of a director of the Group.
As at 31 December 2016, there were no directors in the Group’s defined contribution scheme (2015: nil).
The remuneration paid to other Key Management Personnel for their services to the Group was as follows:
Group
2016
$’000
2015
$’000
Aggregate wages and salaries 5,371 8,075
Short-term monetary benefits 33 64
Defined pension cost 40 46
5,444 8,185
Marex Spectron Group Limited
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2016 (CONTINUED)
85
35. RELATED PARTY TRANSACTIONS (CONTINUED)
(c) Key Management Personnel transactions
The Group made loans to certain directors associated with equity awards of $141,971 (2015: $145,873). In
addition, the Group made loans to certain senior current and former employees relating to tax payments
associated with equity awards of $293,561 (2015: $795,350). The loans are non-interest bearing and will be
repayable under the terms of the equity award arising at the liquidating event.
During the year, certain employee directors of the Company were part of a long-term senior management
compensation plan arranged by the majority shareholders of the Company. The majority of the
compensation plan payable under these arrangements is contingent upon sale of the Company and the sale
price being at a level which provides all the shareholders of the Company with a profit. A minority of the
compensation plan is contingent on the profits of the Company exceeding a given threshold over a multi-year
period. The only time when the company will be required to make a payment under this plan would be when
it is sold by its shareholders.
(d) Transactions with entities having significant influence over the Group
Balances and transactions between the Company and its subsidiaries which are related parties have been
eliminated on consolidation and not disclosed in this note.
The Group pays management fees to parties associated with the ultimate parent company based on a
percentage of the Group’s profitability amounting to $767,560 (2015: $703,308).
During the year, the Group received consortium relief from entities that have significant influence over the
Group of $815,892 (2015: $1,174,000). The payable balance at 31 December 2016 was $567,660 (2015:
$7,596,000).